<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Pharmacology-2) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 7040,
    "choices": [
      {
        "id": 28128,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketoconazole</span></span></span></p>"
      },
      {
        "id": 28129,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertaconazole</span></span></span></p>"
      },
      {
        "id": 28130,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luliconazole</span></span></span></p>"
      },
      {
        "id": 28131,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terbinafine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following topical antifungal has both anti- inflammatory effects and anti-pruritic action? (</span></span>INICET May 2020)</p>",
    "unique_key": "Q2572608",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305583,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Sertaconazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertaconazole has both anti-inflammatory effects and anti-pruritic action. It is used to treat dermatophytosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketoconazole:&nbsp;</span></strong>Ketoconazole is a broad-spectrum antifungal that also has anti-androgenic effects. However, it does not possess notable anti-inflammatory or anti-pruritic properties.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luliconazole:&nbsp;</span></strong>Luliconazole is effective against dermatophytes and yeasts, but it does not have significant anti-inflammatory or anti-pruritic actions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terbinafine:&nbsp;</span></strong>Terbinafine is mainly used to treat dermatophytosis. It does not have substantial anti-inflammatory or anti-pruritic effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-101732.png\" style=\"height:681px; width:1000px\" /></p>",
    "correct_choice_id": 28129,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7041,
    "choices": [
      {
        "id": 28132,
        "text": "<p><span style=\"font-size:12pt;\">Malaise and sore throat</span></p>"
      },
      {
        "id": 28133,
        "text": "<p><span style=\"font-size:12pt;\">Ataxia and Diarrhea</span></p>"
      },
      {
        "id": 28134,
        "text": "<p><span style=\"font-size:12pt;\">Fever</span></p>"
      },
      {
        "id": 28135,
        "text": "<p><span style=\"font-size:12pt;\">Breathlessness</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 35-year-old patient with a history of bipolar disorder has recently been started on lithium therapy. During a follow-up visit, the healthcare provider wants to educate the patient on the signs of lithium toxicity. Which of the following side effects should the patient be instructed to monitor and report immediately as they may indicate lithium toxicity? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q5831874",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305584,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Ataxia and Diarrhea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ataxia, tinnitus and diarrhea are common signs of lithium toxicity. Lithium has a narrow therapeutic range, meaning that the difference between a therapeutic dose and a toxic dose is small. Therefore, monitoring for signs of toxicity is crucial. Other signs of lithium toxicity can include tremors, confusion, and vomiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Malaise and sore throat:</strong> While these symptoms can be concerning, they are not typically associated with lithium toxicity. They might be indicative of an infection or other unrelated conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Fever:</strong> Fever is not a common sign of lithium toxicity. It may indicate an infection or other illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Breathlessness:</strong> This symptom is not typically associated with lithium toxicity. Breathlessness might be related to other medical conditions such as respiratory or cardiac issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, patients on lithium therapy should be particularly vigilant for symptoms like ataxia and diarrhea, as they could indicate the onset of lithium toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Patients on lithium therapy should be educated to monitor and immediately report signs of lithium toxicity, such as ataxia and diarrhea, to prevent serious adverse effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Mnemonic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">If <strong>DAT</strong> symptom is present, report to hospital:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>D</strong>iarrhea</span></li><li><span style=\"font-size:12pt;\"><strong>A</strong>taxia</span></li><li><span style=\"font-size:12pt;\"><strong>T</strong>innitus</span></li></ul>",
    "correct_choice_id": 28133,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7042,
    "choices": [
      {
        "id": 28136,
        "text": "<p><span style=\"font-size:12pt;\">After 24 hours</span></p>"
      },
      {
        "id": 28137,
        "text": "<p><span style=\"font-size:12pt;\">After 12 hours</span></p>"
      },
      {
        "id": 28138,
        "text": "<p><span style=\"font-size:12pt;\">After 6 hours</span></p>"
      },
      {
        "id": 28139,
        "text": "<p><span style=\"font-size:12pt;\">Immediately after taking tablets</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A psychiatric patient was started on lithium for the management of bipolar disorder. To monitor the blood lithium levels, at what time interval should the blood sample be collected after the administration of lithium tablets? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q6009909",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305585,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. After 12 hours</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Lithium has a very narrow therapeutic index; therefore, the blood levels of lithium have to be monitored. Blood samples to measure lithium levels are typically collected 12 hours after the last dose. This timing is chosen because it represents the 'trough' level \u2013 the lowest concentration of the drug in the bloodstream before the next dose is due. Measuring at this point helps to ensure that the lithium level stays within the therapeutic range and avoids toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Plasma Levels of Lithium:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">For prophylaxis of mania \u2013 0.5 \u2013 0.7 mEq/L</span></li><li><span style=\"font-size:12pt;\">For acute mania \u2013 0.8 \u2013 1.2 mEq/L</span></li><li><span style=\"font-size:12pt;\">Toxicity is seen when it is &gt; 1.5 mEq/L</span></li><li><span style=\"font-size:12pt;\">Dialysis is required at levels &gt;4 mEq/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To monitor lithium levels accurately and ensure they remain within the therapeutic range, blood samples should be collected 12 hours after the last dose. This helps in avoiding toxicity and ensuring the efficacy of the treatment for bipolar disorder.</span></p>",
    "correct_choice_id": 28137,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7043,
    "choices": [
      {
        "id": 28140,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid</span></span></span></p>"
      },
      {
        "id": 28141,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethionamide</span></span></span></p>"
      },
      {
        "id": 28142,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyclovir</span></span></span></p>"
      },
      {
        "id": 28143,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a second line anti-tubercular drug? (</span></span></span>INICET May 2020)</p>",
    "unique_key": "Q4422356",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305586,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Ethionamide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethionamide is used as a second-line treatment for tuberculosis (TB), particularly in cases of multidrug-resistant TB (MDR-TB), when the first-line drugs (like isoniazid, rifampicin, ethambutol, and pyrazinamide) are not effective or cannot be used due to resistance or side effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Isoniazid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a first-line anti-tubercular drug, widely used in the treatment of both latent and active TB infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acyclovir:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Acyclovir is an antiviral medication, primarily used for the treatment of herpes simplex virus infections and not for tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vancomycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Vancomycin is an antibiotic used to treat serious bacterial infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is not used in the treatment of tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethionamide is a second-line anti-tubercular drug used in the management of multidrug-resistant tuberculosis (MDR-TB), whereas isoniazid is a first-line drug, and acyclovir and vancomycin are not used for tuberculosis treatment.</span></span></span></p>",
    "correct_choice_id": 28141,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30722,
    "choices": [
      {
        "id": 122766,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Paracetamol</span></span></span></span></p>"
      },
      {
        "id": 122767,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Valproate</span></span></span></span></p>"
      },
      {
        "id": 122768,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Warfarin</span></span></span></span></p>"
      },
      {
        "id": 122769,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Tetracycline</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Most&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">commonly implicated drug for causation of acute liver failure is? (AIIMS MAY 2020</span></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">)</span></span></span></span></p>",
    "unique_key": "Q3772003",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305587,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A. Paracetamol</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">All the four drugs given Paracetamol, Valproate, Warfarin and Tetracyclines can cause hepatotoxicity. Paracetamol among these is the most common cause particularly in patients with liver disease and in alcoholics.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Paracetamol is the most common cause of acute liver failure in many countries, particularly in the context of overdose. It can cause severe hepatotoxicity, which can lead to acute liver failure, especially when taken in doses exceeding recommended levels or in individuals with certain risk factors (such as existing liver disease and chronic alcohol use etc.).</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Other Options: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Valproate</strong>: While valproate can cause hepatotoxicity, it is less commonly associated with acute liver failure compared to paracetamol. It is more frequently a concern in certain populations, such as young children and individuals on multiple anticonvulsants.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Warfarin</strong>: Warfarin is an anticoagulant and is not commonly associated with acute liver failure. Its primary risk is bleeding due to its anticoagulant effects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Tetracycline</strong>: High doses of tetracycline, especially the older formulations, can cause liver toxicity, but it is not the most common drug causing acute liver failure. Tetracycline-induced liver injury is now relatively rare due to the decreased use of high-dose intravenous forms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paracetamol (acetaminophen) is the most common drug implicated in the causation of acute liver failure, especially in the context of overdose and in individuals with risk factors like existing liver disease and chronic alcohol use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/223</span></span></strong></span></span></p>",
    "correct_choice_id": 122766,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30725,
    "choices": [
      {
        "id": 122778,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-A, 2-B, 3-C, 4-D</span></span></span></span></p>"
      },
      {
        "id": 122779,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-D, 2-F, 3-E, 4-C</span></span></span></span></p>"
      },
      {
        "id": 122780,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-D, 2-A, 3-C 4-E</span></span></span></span></p>"
      },
      {
        "id": 122781,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-D, 2-C, 3-F, 4-E</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Match&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">the following drugs with their ocular adverse effects?</span></span></span></span>(AIIMS MAY 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-171440.png\" style=\"height:403px; width:1000px\" /></p>",
    "unique_key": "Q8709371",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305588,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">D. 1-D, 2-C, 3-F, 4-E</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following are the drugs and their associated ocular adverse effects:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is known to cause corneal deposits (cornea verticillata) and optic neuritis. The correct match for Amiodarone is D (Optic neuritis).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydroxychloroquine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is associated with bull&rsquo;s eye maculopathy, a specific type of retinopathy. Therefore, Hydroxychloroquine is correctly matched with C (Retinopathy).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic steroids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: When given topically, systemic steroids can cause open-angle glaucoma. However, when given systemically, they are known to cause posterior subcapsular cataract. Thus, systemic steroids are best matched with F (Cataract).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digoxin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug can cause yellow vision, a condition where the patient perceives a yellow tint in their vision. Hence, Digoxin is correctly matched with E (Yellow vision).</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ocular adverse-effects of drugs:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Amiodarone:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Corneal deposits (cornea verticallata) <strong>Optic neuritis</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Hydroxychloroquine:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Bull&rsquo;s eye maculopathy (<strong>retinopathy</strong>).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Systemic steroids:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Given topically &ndash; cause Open angle Glaucoma; Given systemically &ndash; cause Posterior subcapsular&nbsp;<strong>cataract</strong><strong>.</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Digoxin:</strong>&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Yellow vision</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/880, 318, 560, Goodman Gilman 13<sup>th</sup>/&nbsp; 564</span></span></strong></span></span></p>",
    "correct_choice_id": 122781,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7046,
    "choices": [
      {
        "id": 28152,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Protamine sulphate</span></span></span></p>"
      },
      {
        "id": 28153,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dalteparin</span></span></span></p>"
      },
      {
        "id": 28154,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epsilon Amino Caproic Acid</span></span></span></p>"
      },
      {
        "id": 28155,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alteptase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the antidote for fibrinolytic therapy? (</span></span>INICET May 2020)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
    "unique_key": "Q6880598",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305589,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Epsilon Amino Caproic Acid</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibrinolytic therapy involves the use of drugs (like alteplase, streptokinase, etc.) to break down blood clots. Epsilon Amino Caproic Acid (EACA) and tranexamic acid are antifibrinolytic agents that can be used to counteract bleeding due to excessive fibrinolysis, which can occur during or after fibrinolytic therapy. These work by inhibiting plasminogen activators and, to a lesser degree, plasmin activity, thereby reducing the breakdown of fibrin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Protamine Sulphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is used as an antidote for heparin overdose, not for fibrinolytic therapy. Protamine sulphate binds to and inactivates heparin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dalteparin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Dalteparin is a low molecular weight heparin and is an anticoagulant itself. It is not used as an antidote for fibrinolytic therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Alteplase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Alteplase is a fibrinolytic agent, not an antidote. It is used to dissolve blood clots in conditions like acute ischemic stroke, pulmonary embolism, and myocardial infarction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epsilon Amino Caproic Acid is the antidote for fibrinolytic therapy, used to counteract excessive bleeding due to fibrinolysis. It works by inhibiting plasminogen activators and stabilizing clots.</span></span></span></p>",
    "correct_choice_id": 28154,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7045,
    "choices": [
      {
        "id": 28148,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></span></p>"
      },
      {
        "id": 28149,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saxagliptin</span></span></span></p>"
      },
      {
        "id": 28150,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vildagliptin</span></span></span></p>"
      },
      {
        "id": 28151,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linagliptin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs does not need dose adjustment in renal failure? (</span></span>INICET May 2020)</p>",
    "unique_key": "Q1530757",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305590,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Linagliptin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the treatment of type 2 diabetes. Unlike other DPP-4 inhibitors, linagliptin is primarily excreted via the enterohepatic system, with only a small fraction eliminated by the kidneys. Therefore, it does not require dose adjustments in patients with renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sitagliptin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This DPP-4 inhibitor is primarily excreted by the kidneys, and its dose usually needs to be adjusted in patients with renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Saxagliptin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Saxagliptin and its active metabolite are primarily eliminated by the kidneys, necessitating dose adjustments in patients with renal failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vildagliptin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Vildagliptin is partially excreted by the kidneys, and dose adjustment is recommended in patients with moderate to severe renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linagliptin is a unique DPP-4 inhibitor that does not require dose adjustments in patients with renal failure due to its primary excretion via the enterohepatic system. This makes it an advantageous option for managing type 2 diabetes in patients with compromised renal function.</span></span></span></p>",
    "correct_choice_id": 28151,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7044,
    "choices": [
      {
        "id": 28144,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid</span></span></span></p>"
      },
      {
        "id": 28145,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifapentin</span></span></span></p>"
      },
      {
        "id": 28146,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioacetazone</span></span></span></p>"
      },
      {
        "id": 28147,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kanamycin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anti-tubercular drug is not bactericidal? (</span></span>INICET May 2020)</p>",
    "unique_key": "Q3921200",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305591,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Thioacetazone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioacetazone is a bacteriostatic anti-tubercular drug. Bacteriostatic drugs inhibit the growth and replication of bacteria, rather than killing them outright. Thioacetazone is less commonly used nowadays due to its side effects and the availability of more effective treatments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Isoniazid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Isoniazid is a bactericidal drug against actively dividing Mycobacterium tuberculosis bacteria. It works by inhibiting the synthesis of mycolic acid, a critical component of the bacterial cell wall.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rifapentin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rifapentin is a bactericidal antibiotic and is a derivative of rifampicin. It works by inhibiting bacterial RNA synthesis and is used primarily in the treatment of tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Kanamycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Kanamycin is an aminoglycoside antibiotic and is bactericidal. It works by inhibiting bacterial protein synthesis. It is used as a second-line drug for the treatment of multidrug-resistant tuberculosis (MDR-TB).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioacetazone is a bacteriostatic anti-tubercular drug, which means it inhibits bacterial growth rather than killing the bacteria outright. In contrast, isoniazid, rifapentin, and kanamycin are all bactericidal drugs used in the treatment of tuberculosis.</span></span></span></p>",
    "correct_choice_id": 28146,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30720,
    "choices": [
      {
        "id": 122758,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-A, 2-E, 3-B, 4-C</span></span></span></p>"
      },
      {
        "id": 122759,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-F, 2- E, 3-D, 4- B</span></span></span></p>"
      },
      {
        "id": 122760,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-F, 2-E, 3-B, 4-A</span></span></span></span></p>"
      },
      {
        "id": 122761,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-B, 2-C, 3-D, 4-E</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Match&nbsp;</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">the following drugs poisoning with the antidotes:(AIIMS MAY 2019)&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-163314.png\" style=\"height:498px; width:1000px\" /></p>",
    "unique_key": "Q3684140",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305592,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">C. 1-F, 2-E, 3-B, 4-A</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. HCN (Hydrogen Cyanide):</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antidote: <strong>F. Amyl nitrite</strong><br />\r\n\tHCN poisoning, also known as cyanide poisoning, is treated with amyl nitrite, which induces methemoglobinemia, allowing cyanide to bind to methemoglobin instead of cytochrome oxidase, reducing its toxicity. The DOC for cyanide poisoning is Hydroxocobalamine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Paracetamol (Acetaminophen):</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antidote: <strong>E. N-acetylcysteine</strong><br />\r\n\tN-acetylcysteine replenishes glutathione stores, helping detoxify the reactive metabolite of paracetamol, thereby preventing liver damage.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. Morphine:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antidote: <strong>B. Nalorphine</strong><br />\r\n\tNalorphine is an opioid antagonist used to counteract the effects of opioid overdose, including morphine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. Nicotine:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antidote: <strong>A. Trimethadione</strong><br />\r\n\tTrimethadione is used in cases of nicotine poisoning due to its ganglionic blocking properties, similar to the Nn receptor blockers (ganglionic blockers) like Trimethaphan and Hexamethonium.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">HCN poisoning:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">DOC is Hydroxocobalamin. Amyl Nitrite(inhalational) with sodium thiosulphate (iv) can also be used.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Paracetamol poisoning (causes hepatoxicity):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">N-acetylcysteine is used.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Morphine poisoning:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">DOC is Naloxone. Nalorphine can also be used.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Nicotine poisoning:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Trimethaphan and Hexamethonium &ndash; Nn receptor blockers </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">(ganglionic blockers) are used.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/590, 223, 509, 134</span></span></strong></span></span></p>",
    "correct_choice_id": 122760,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6920,
    "choices": [
      {
        "id": 27648,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.5 ml of 1:1000 adrenaline by intramuscular route</span></span></span></p>"
      },
      {
        "id": 27649,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.5 ml of 1:1000 adrenaline by intravenous route</span></span></span></p>"
      },
      {
        "id": 27650,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.5 ml of 1:10000 adrenaline by intramuscular route</span></span></span></p>"
      },
      {
        "id": 27651,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.5 ml of 1:10000 adrenaline by intravenous route</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient&nbsp;was given ampicillin 2 g intravenously. After that, the person developed rash on skin, hypotension and difficulty in breathing. The patient should be managed by? (</span></span>AIIMS Nov 2019)</p>",
    "unique_key": "Q6031447",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305593,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. A. 0.5 ml of 1:1000 adrenaline by intramuscular route</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Penicillin&rsquo;s are prone to cause allergic reactions. Features like rash on skin, hypotension, and difficulty in breathing are suggestive of anaphylactic shock.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">In case of anaphylactic shock the resuscitation council of UK has recommended the following measures:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Put the patient in reclining position, administer oxygen at high flow rate and perform cardiopulmonary resuscitation if required.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Inject adrenaline 0.5 mg (0.5 ml of 1 in 1000 for adult, 0.3 ml for child 6-12 years and 0.15 ml for child upto 6 years) i.m.; repeat every 5-10 min in case patient does not improve or improvement is transient. This is the only life saving measure. Adrenaline should not be injected i.v. (can itself be fatal) unless shock is immediately life threatening. If adrenaline is to be injected i. v., it should be diluted to 1:10,000 and infused slowly with constant monitoring.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Administer a H1 antihistaminic (pheniramine 20-40 mg or chlorpheniramine 10-20 mg) i.m./slow i.v. It may have adjuvant value.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Intravenous glucocorticoid (hydrocortisone sod. succinate 200 mg) should be added in severe/recurrent cases. It acts slowly but is especially valuable for prolonged reactions and in asthmatics. It may be followed by oral prednisolone for 3 days.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-185948.jpg\" style=\"height:331px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reference: KDT 8<sup>th</sup>/ 97</span></strong></span></span></p>",
    "correct_choice_id": 27648,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6916,
    "choices": [
      {
        "id": 27632,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Radical cure of Plasmodium vivax</span></span></span></span></p>"
      },
      {
        "id": 27633,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Prophylaxis of malaria in pregnancy</span></span></span></span></p>"
      },
      {
        "id": 27634,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Treatment of severe falciparum malaria</span></span></span></span></p>"
      },
      {
        "id": 27635,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Treatment of endemic malaria in children &lt; 2 years</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">W</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">hich of the following is clinical use of tafenoquine? (</span></span></span></span>AIIMS Nov 2019</p>",
    "unique_key": "Q6320791",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305594,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. A. Radical cure of Plasmodium vivax</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Radical cure &ndash;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"> Several patients of P. vivax malaria relapse due to persistence of exo-erythrocytic stage. Drugs which attack this stage (hypnozooites) given together with a clinical curative achieve total eradication of the parasite from the patient&#39;s body.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug of choice for radical cure of vivax and ovale malaria is:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Primaquine 15 mg daily for 14 days</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Tafenoquine is a new long-acting exo-erythrocytic schizontocidal drug. It has been developed as a single dose radical cure for vivax malaria.</span></span></span></span></li>\r\n</ul>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Prophylaxis of malaria in pregnancy:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tafenoquine is not recommended for malaria prophylaxis in pregnancy due to its potential for causing hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Pregnant women are typically advised to use other antimalarial drugs for prophylaxis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Treatment of severe falciparum malaria:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The treatment of severe falciparum malaria typically involves intravenous administration of drugs like artesunate or quinine, rather than tafenoquine. Tafenoquine is not used in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Treatment of endemic malaria in children &lt; 2 years:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tafenoquine is not recommended for use in children under 2 years of age. The safety and efficacy of tafenoquine in this age group have not been established, and alternative antimalarial therapies are preferred for young children.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tafenoquine is used for the radical cure of Plasmodium vivax malaria due to its long-acting effects against the exo-erythrocytic stage of the parasite, helping to prevent relapses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/. 878</span></span></strong></span></span></p>",
    "correct_choice_id": 27632,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6922,
    "choices": [
      {
        "id": 27656,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral neuropathy is a common adverse effect</span></span></span></p>"
      },
      {
        "id": 27657,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is active against gram positive organisms</span></span></span></p>"
      },
      {
        "id": 27658,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It has poor oral bioavailability</span></span></span></p>"
      },
      {
        "id": 27659,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Major mode of elimination is renal excretion</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">W</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">hich of the following statements about tedizolid is true? (</span></span></span></span>AIIMS Nov 2019)</p>",
    "unique_key": "Q3514529",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305595,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. B. It is active against gram positive organisms</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tedizolid is an oxazolidinone-class antibiotic, similar to linezolid, and is primarily used to treat infections caused by gram-positive bacteria.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Activity Against Gram-Positive Organisms</span></strong><span style=\"font-size:12.0pt\">: Tedizolid is particularly effective against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA). It works by inhibiting protein synthesis through binding to the 50S ribosomal subunit.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Peripheral neuropathy is a common adverse effect:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Peripheral neuropathy and lactic acidosis are potential adverse effects of tedizolid, but they are not common.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. It has poor oral bioavailability:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Tedizolid has very good oral bioavailability, nearly 90%, making it effective when administered orally.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Major mode of elimination is renal excretion:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Tedizolid is primarily metabolized in the liver, and renal excretion is not the major route of elimination.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tedizolid is a protein synthesis inhibitor that is primarily active against gram-positive organisms, including resistant strains like MRSA and VRSA. It has good oral bioavailability and is primarily metabolized in the liver.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/808</span></span></strong></span></span></p>",
    "correct_choice_id": 27657,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7023,
    "choices": [
      {
        "id": 28060,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Herbal medication with no effect known</span></span></span></p>"
      },
      {
        "id": 28061,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiotherapy</span></span></span></p>"
      },
      {
        "id": 28062,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sham surgery</span></span></span></p>"
      },
      {
        "id": 28063,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cognitive behavioral therapy</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one of the following is a placebo? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q9761559",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305596,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Sham surgery</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sham surgery (placebo surgery) is a fictitious surgical intervention when the actual step that is of therapeutic benefit is omitted. For example, opening the abdomen and then again suturing it without any sort of intervention done on the viscera.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Herbal medication with no effect known</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While an herbal medication with no known effect might be considered a placebo in certain contexts, it is not specifically designed as a placebo. It could contain active ingredients with unknown effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physiotherapy</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Physiotherapy is an established therapeutic practice with known benefits for various conditions. It is not a placebo.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cognitive behavioral therapy</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cognitive behavioral therapy (CBT) is a well-established psychological treatment for a variety of mental health conditions. It is not a placebo, as it involves specific therapeutic techniques aimed at changing maladaptive thinking and behavior patterns.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sham surgery is a type of placebo where the therapeutic intervention is omitted, used primarily in clinical trials to control for the placebo effect and test the efficacy of surgical procedures.</span></span></span></p>",
    "correct_choice_id": 28062,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7047,
    "choices": [
      {
        "id": 28156,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low molecular weight heparin</span></span></span></p>"
      },
      {
        "id": 28157,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxygen</span></span></span></p>"
      },
      {
        "id": 28158,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Favipiravir</span></span></span></p>"
      },
      {
        "id": 28159,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steroids</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is least likely to be useful in a patient with severe COVID-19?</span></span></span></p>",
    "unique_key": "Q3407137",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305597,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Favipiravir</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Favipiravir is an antiviral drug that has been studied for use in COVID-19, but its effectiveness, particularly in severe cases, is less clear compared to other treatments. Favipiravir is known to work against RNA viruses, but its role in the treatment of severe COVID-19 has not been established as a standard of care.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Low Molecular Weight Heparin (LMWH):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with severe COVID-19 are at increased risk of thromboembolic events. LMWH is used to prevent blood clots and is an important part of the management of hospitalized COVID-19 patients, especially those with severe disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Oxygen:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oxygen therapy is crucial for patients with severe COVID-19, especially those experiencing respiratory distress and hypoxemia (low blood oxygen levels). It is a key supportive treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Steroids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Corticosteroids like dexamethasone have been shown to reduce mortality in patients with severe and critical COVID-19, particularly those requiring respiratory support. They are used to reduce inflammation in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Favipiravir is least likely to be useful in a patient with severe COVID-19 compared to low molecular weight heparin, oxygen, and steroids, which have well-established roles in managing severe cases of the disease.</span></span></span></p>",
    "correct_choice_id": 28158,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7048,
    "choices": [
      {
        "id": 28160,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Should not be used due to risk of addiction</span></span></span></p>"
      },
      {
        "id": 28161,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be used as both have different mechanism of action</span></span></span></p>"
      },
      {
        "id": 28162,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Should not be used as it is irrational</span></span></span></p>"
      },
      {
        "id": 28163,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be used to treat cough effectively</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If Codeine is coming to the market in combination with dextromethorphan as an anti-tussive, this combination? (</span></span>INICET May 2020)</p>",
    "unique_key": "Q3290929",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305598,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Should not be used as it is irrational</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Codeine is an opioid agonist and Dextromethorphan is a centrally acting NMDA receptor antagonist. Both codeine and dextromethorphan are antitussives, but they work through similar central mechanisms to suppress cough. Combining them does not offer additional therapeutic benefits but can increase the risk of side effects</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A rational fixed dose drug combination would be to combine one centrally acting anti-tussive (either codeine or dextromethorphan) with expectorants (like potassium iodide, Guaifenesin), antihistaminic and mucolytics like (Ambroxol, Bromhexine, Acetyl cysteine)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Should not be used due to risk of addiction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While codeine has a potential for addiction, the main concern with this combination is not solely the risk of addiction but the lack of rationality in combining two centrally acting antitussives.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Can be used as both have different mechanisms of action:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is incorrect. Codeine and dextromethorphan both act centrally to suppress cough, and their mechanisms are similar enough that combining them does not provide a significant therapeutic advantage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Can be used to treat cough effectively:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Although both drugs are effective cough suppressants individually, their combination is not advisable due to the redundancy in action and increased risk of side effects without additional therapeutic benefit.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, the most accurate answer is C. The combination should not be used as it is irrational due to the overlapping mechanisms of action and increased risk of adverse effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Combining codeine with dextromethorphan as an anti-tussive is irrational due to their overlapping mechanisms of action and the increased risk of side effects without additional therapeutic benefit. Rational combinations for cough treatment involve combining one centrally acting antitussive with expectorants, antihistamines, and mucolytics.</span></span></span></p>",
    "correct_choice_id": 28162,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30729,
    "choices": [
      {
        "id": 122794,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-A, 2-C, 3-C, 4-D</span></span></span></span></p>"
      },
      {
        "id": 122795,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-B, 2-C, 3-D, 4-E</span></span></span></span></p>"
      },
      {
        "id": 122796,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-D, 2-A, 3-B, 4-F</span></span></span></span></p>"
      },
      {
        "id": 122797,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-D, 2-B, 3-A, 4-F</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Match&nbsp;</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">the following drugs with the organism they are used for? (AIIMS MAY 2019)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-164026.png\" style=\"height:386px; width:1000px\" /></p>",
    "unique_key": "Q9784242",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305599,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">C. 1-D, 2-A, 3-B, 4-F</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct matches based on the given drugs and organisms:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Praziquantal</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is primarily used for the treatment of flukes (except liver fluke) and tapeworms (except dog tapeworm). Therefore, the correct match for Praziquantal is D (Tapeworms).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Di Ethyl Carbamezine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is the drug of choice for the treatment of filariasis, making A (Filaria) the correct match.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitazoxanide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is used for Cryptosporidium and also for Giardia. However, the drug of choice for Giardia is metronidazole or tinidazole, but Nitazoxanide is also effective against Giardia. Therefore, the correct match for Nitazoxanide is B (Giardia).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mebendazole</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is used for treating various nematodes, including Ascaris lumbricoides. Therefore, the correct match for Mebendazole is F (Ascaris lumbricoides).</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug of choice for treatment of flukes (except liver fluke) and tapeworms (except dog tapeworm) is&nbsp;<strong>Praziquantal</strong>.</span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug of choice for treatment of liver fluke is triclabendazole.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug of choice for dog tapeworm (Echinococcus) is albendazole</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug of choice for all nematodes (see exceptions below) is albendazole (or&nbsp;<strong>Mebendazole</strong>)</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug of choice for treatment of filariasis is&nbsp;<strong>Diethylcarbamazine</strong>.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug of choice for treatment of Onchocerca and Strongyloides is ivermectin.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Nitazoxanide</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">: DOC for Cryptosporidium and also used for Giardia (DOC is metronidazole and tinidazole)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/907</span></span></strong></span></span></p>",
    "correct_choice_id": 122796,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7022,
    "choices": [
      {
        "id": 28056,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsulosin</span></span></p>"
      },
      {
        "id": 28057,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sildenafil</span></span></p>"
      },
      {
        "id": 28058,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride</span></span></p>"
      },
      {
        "id": 28059,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flutamide</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The drug that decreases the size of prostate is? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q2546777",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305600,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Finasteride</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Finasteride: It inhibits the conversion of testosterone into its active form, DHT (dihydrotestosterone), by acting as a competitive inhibitor of the 5-reductase enzyme. It&nbsp;has a&nbsp;long-term effect of&nbsp;reducing prostatic epithelial cell proliferation, which reduces the size of the prostate and improves urine flow.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tamsulosin is a Selective &alpha;1A Antagonist which dilates prostatic urethra and hence produces immediate symptom relief in BPH. It has no effect on reducing size of the prostate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flutamide is a Androgen Receptor antagonist with no hormonal activity. It is used for the treatment of metastatic prostatic cancer in conjunction with GnRH agonists.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsulosin</span></strong>: Tamsulosin is a selective alpha-1A adrenergic receptor antagonist. It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. While it provides symptomatic relief for BPH, it does not reduce the size of the prostate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sildenafil</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor used primarily for the treatment of erectile dysfunction. It has no effect on prostate size.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flutamide</span></strong>: Flutamide is an androgen receptor antagonist that is used in the treatment of metastatic prostate cancer. It does not reduce the size of the prostate but works by blocking the effects of androgens (male hormones).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride decreases the size of the prostate by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), thereby reducing prostatic cell proliferation and improving urinary symptoms in patients with benign prostatic hyperplasia.</span></span></p>",
    "correct_choice_id": 28058,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6935,
    "choices": [
      {
        "id": 27708,
        "text": "<p><span style=\"font-size:12.0pt;\">Increased CAMP</span></p>"
      },
      {
        "id": 27709,
        "text": "<p><span style=\"font-size:12.0pt;\">Stimulation of guanylyl cyclase</span></p>"
      },
      {
        "id": 27710,
        "text": "<p><span style=\"font-size:12.0pt;\">Calcium channel blockage</span></p>"
      },
      {
        "id": 27711,
        "text": "<p><span style=\"font-size:12.0pt;\">K+ channel opener</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the mechanism of action of sodium nitroprusside? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q1796801",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305601,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Stimulation of guanylyl cyclase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sodium nitroprusside is a potent vasodilator that works by stimulating guanylyl cyclase. When sodium nitroprusside enters the bloodstream, it rapidly releases nitric oxide (NO). This NO then activates guanylyl cyclase in vascular smooth muscle cells. The activation of guanylyl cyclase increases the conversion of GTP to cyclic GMP (cGMP). Elevated levels of cGMP lead to the dephosphorylation of myosin light chains, resulting in relaxation of vascular smooth muscle and subsequent vasodilation. This mechanism effectively reduces blood pressure and is used in the management of hypertensive emergencies and severe heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increased cAMP:&nbsp;</strong>Drugs that increase cAMP, such as beta-adrenergic agonists, work through different mechanisms involving the activation of adenylate cyclase, not guanylyl cyclase. cAMP primarily mediates actions like increased heart rate and bronchodilation, which is not the primary action of sodium nitroprusside.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Calcium channel blockage:&nbsp;</strong>Calcium channel blockers, such as verapamil and diltiazem, inhibit the influx of calcium ions into cardiac and smooth muscle cells, leading to muscle relaxation and vasodilation. Sodium nitroprusside does not act through this pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. K+ channel opener:&nbsp;</strong>Potassium channel openers, such as minoxidil, work by hyperpolarizing the cell membrane, leading to relaxation of vascular smooth muscle. This is not the mechanism of action of sodium nitroprusside.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sodium nitroprusside acts by stimulating guanylyl cyclase, which leads to an increase in cGMP, causing relaxation of vascular smooth muscle and vasodilation. This makes it effective in rapidly reducing blood pressure in hypertensive emergencies.</span></p>",
    "correct_choice_id": 27709,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6937,
    "choices": [
      {
        "id": 27716,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transmembrane receptor linked to tyrosine kinase</span></span></span></p>"
      },
      {
        "id": 27717,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nuclear receptor</span></span></span></p>"
      },
      {
        "id": 27718,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ion channel receptor</span></span></span></p>"
      },
      {
        "id": 27719,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G protein coupled receptor</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levothyroxine/liothyronine acts by binding to thyroid receptors. Thyroid hormone receptors belong to which of the following class of receptors?</span></span></p>",
    "unique_key": "Q6644477",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305602,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Nuclear receptor</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thyroid hormone receptors (TRs) are part of the nuclear receptor superfamily. These receptors are located intracellularly, primarily within the nucleus, and function as transcription factors that regulate gene expression. When thyroid hormones (such as levothyroxine and liothyronine) enter the cell, they bind to these nuclear receptors. The hormone-receptor complex then binds to specific DNA sequences in the promoter regions of target genes, leading to modulation of gene transcription and subsequent protein synthesis. This process is crucial for the regulation of metabolism, growth, and development.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Transmembrane receptor linked to tyrosine kinase:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This class includes receptors such as the insulin receptor and epidermal growth factor receptor (EGFR). These receptors span the cell membrane and, upon ligand binding, activate tyrosine kinase activity leading to a cascade of intracellular signaling events. Thyroid hormone receptors do not belong to this class.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ion channel receptor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Ion channel receptors, also known as ligand-gated ion channels, open or close in response to the binding of a chemical messenger (ligand), such as neurotransmitters. Examples include the nicotinic acetylcholine receptor and GABA receptor. Thyroid hormone receptors do not function in this manner.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. G protein coupled receptor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">G protein-coupled receptors (GPCRs) are membrane receptors that, upon ligand binding, activate G proteins which then trigger various intracellular signaling pathways. Examples include adrenergic receptors and muscarinic acetylcholine receptors. Thyroid hormone receptors are not GPCRs.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thyroid hormone receptors are intracellular and intranuclear receptors. They primarily function as transcription factors and directly interact with the genomic DNA to regulate gene expression.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other examples of intranuclear receptors include Vitamin A and Vitamin D receptors.</span></span></span></p>",
    "correct_choice_id": 27717,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6940,
    "choices": [
      {
        "id": 27728,
        "text": "<p><span style=\"font-size:12.0pt;\">Discovery of mechanisms of autophagy</span></p>"
      },
      {
        "id": 27729,
        "text": "<p><span style=\"font-size:12.0pt;\">Discoveries of molecular mechanisms controlling the circadian rhythm</span></p>"
      },
      {
        "id": 27730,
        "text": "<p><span style=\"font-size:12.0pt;\">Discovery of cancer therapy by inhibition of negative immune regulation</span></p>"
      },
      {
        "id": 27731,
        "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Discovery that mature cells can be reprogrammed to become pluripotent</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The Nobel Prize in Physiology or Medicine, 2018 was awarded to James P. Allison and Tasuku Honjo for which of the following discoveries? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q8993651",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305603,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C.&nbsp; Discovery of cancer therapy by inhibition of negative immune regulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Nobel Prize in Physiology or Medicine for 2018 was awarded jointly to James P. Allison and Tasuku Honjo for their pioneering work in cancer therapy by inhibition of negative immune regulation. Their research focused on understanding how the immune system can be harnessed to fight cancer, specifically through the mechanism of immune checkpoint inhibitors.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>James P. Allison</strong> discovered that the protein CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) acts as a brake on T cells. By inhibiting CTLA-4, it is possible to boost the immune system's response against cancer cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tasuku Honjo</strong> discovered a different protein, PD-1 (programmed cell death protein 1), which also functions as an immune checkpoint. Blocking PD-1 can similarly enhance the immune system's ability to attack cancer cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These discoveries have led to the development of drugs known as immune checkpoint inhibitors, which have significantly improved treatment outcomes for various types of cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Discovery of mechanisms of autophagy:&nbsp;</strong>The Nobel Prize in Physiology or Medicine in 2016 was awarded to Yoshinori Ohsumi for his discoveries of mechanisms for autophagy, a fundamental process for degrading and recycling cellular components.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Discoveries of molecular mechanisms controlling the circadian rhythm:&nbsp;</strong>The Nobel Prize in Physiology or Medicine in 2017 was awarded to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their discoveries of molecular mechanisms controlling the circadian rhythm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Discovery that mature cells can be reprogrammed to become pluripotent:&nbsp;</strong>The Nobel Prize in Physiology or Medicine in 2012 was awarded to John B. Gurdon and Shinya Yamanaka for the discovery that mature cells can be reprogrammed to become pluripotent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immune checkpoint inhibitors function by blocking the proteins that control the immune system's reactions to cancer cells. The immune system's brake is removed when these proteins are inhibited, making it easier for T cells to more efficiently eliminate cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">James P. Allison and Tasuku Honjo were awarded the 2018 Nobel Prize in Physiology or Medicine for their discovery of cancer therapy through inhibition of negative immune regulation.</span></p>",
    "correct_choice_id": 27730,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6943,
    "choices": [
      {
        "id": 27740,
        "text": "<p><span style=\"font-size:18px;\">Gentamicin</span></p>"
      },
      {
        "id": 27741,
        "text": "<p><span style=\"font-size:18px;\">Vancomycin</span></p>"
      },
      {
        "id": 27742,
        "text": "<p><span style=\"font-size:18px;\">Amphotericin B</span></p>"
      },
      {
        "id": 27743,
        "text": "<p><span style=\"font-size:18px;\">Doxycycline</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Which of the following drugs does not require dose reduction in patients with renal failure?</span></p>",
    "unique_key": "Q2604922",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305604,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Doxycycline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Doxycycline is an antibiotic that does not require dose adjustment in patients with renal failure because it is primarily excreted in the bile and not significantly through the kidneys. This makes it safer for use in patients with impaired renal function.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Gentamicin:&nbsp;</strong>Gentamicin is an aminoglycoside antibiotic that is primarily excreted by the kidneys. In patients with renal failure, the clearance of gentamicin is significantly reduced, and therefore, dose adjustments are necessary to avoid toxicity, particularly nephrotoxicity and ototoxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Vancomycin:&nbsp;</strong>Vancomycin is an antibiotic that is also primarily excreted by the kidneys. In patients with renal impairment, dose adjustments are required to prevent accumulation of the drug and subsequent nephrotoxicity and ototoxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Amphotericin B:&nbsp;</strong>Amphotericin B is an antifungal medication that can cause nephrotoxicity. Although its dose does not typically require adjustment based solely on renal function, careful monitoring and possible dose adjustment are often necessary to manage its renal side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>The drugs which are secreted in bile and safe in renal disease include:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Cef in: Cefoperazone, Ceftriaxone</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The: Tigecycline</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">R: Rifampicin</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">E: Erythromycin</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">N: Nafcillin</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A: Ampicillin</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">L: Lincosamide (Clindamycin)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">D: Doxycycline</span></p>",
    "correct_choice_id": 27743,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6944,
    "choices": [
      {
        "id": 27744,
        "text": "<p><span style=\"font-size:12.0pt;\">Cimetidine</span></p>"
      },
      {
        "id": 27745,
        "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine</span></p>"
      },
      {
        "id": 27746,
        "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid</span></p>"
      },
      {
        "id": 27747,
        "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs does not increase the risk of bleeding in patients undergoing warfarin therapy?</span></p>",
    "unique_key": "Q6679185",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305605,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Carbamazepine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Warfarin is an anticoagulant that is metabolized primarily by the CYP2C9 enzyme. The risk of bleeding with warfarin therapy is influenced by drugs that either inhibit or induce the metabolism of warfarin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carbamazepine, is an enzyme inducer. It induces CYP450 enzymes, including CYP2C9, which increases the metabolism of warfarin, leading to reduced plasma warfarin levels and a decreased anticoagulant effect. Therefore, carbamazepine does not increase the risk of bleeding; instead, it can reduce the effectiveness of warfarin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cimetidine:&nbsp;</strong>Cimetidine is a known inhibitor of the CYP450 enzymes, including CYP2C9. By inhibiting this enzyme, cimetidine reduces the metabolism of warfarin, leading to higher plasma concentrations of warfarin and an increased risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Isoniazid:&nbsp;</strong>Isoniazid is an inhibitor of several CYP450 enzymes, including CYP2C9. This inhibition can lead to decreased metabolism of warfarin, increased plasma warfarin levels, and a higher risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amiodarone:&nbsp;</strong>Amiodarone is a potent inhibitor of CYP2C9. It reduces the metabolism of warfarin, resulting in elevated levels of warfarin in the blood and an increased risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Warfarin is mainly metabolized by the CYP2C9 enzyme. Drugs like Cimetidine, Isoniazid, Amiodarone, Clopidogrel, Ketoconazole, Verapamil etc inhibit the enzyme, thus reducing the metabolism of warfarin. This increases the plasma concentration of Warfarin and leads to increased risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carbamazepine is an enzyme inducer and increases the metabolism of warfarin leading to decrease in effect of warfarin.</span></p>",
    "correct_choice_id": 27745,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6946,
    "choices": [
      {
        "id": 27752,
        "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone</span></p>"
      },
      {
        "id": 27753,
        "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
      },
      {
        "id": 27754,
        "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
      },
      {
        "id": 27755,
        "text": "<p><span style=\"font-size:12.0pt;\">Acetazolamide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is used in acute mountain sickness?</span></p>",
    "unique_key": "Q1634633",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305606,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Acetazolamide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetazolamide is the drug of choice for acute mountain sickness. Rapid ascent to high altitudes can lead to the development of headache, nausea, vomiting, dizziness, breathlessness etc. The underlying cause that has been implicated in its causation is cerebral edema. The low PO2 at high altitude causes arteriolar dilation, and if cerebral autoregulation does not compensate, there is an increase in capillary pressure that favors increased transudation of fluid into brain tissue leading to cerebral edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetazolamide is a carbonic anhydrase inhibitor that leads to metabolic acidosis, which in turn stimulates hyperventilation, leading to CO2 washout, and it helps in reducing the formation of CSF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dexamethasone:&nbsp;</strong>Dexamethasone is a corticosteroid and can be used as a treatment for cerebral edema and severe cases of AMS. However, it is not the first-line drug of choice for general AMS prevention or mild cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Digoxin:&nbsp;</strong>Digoxin is a cardiac glycoside used primarily for heart conditions such as atrial fibrillation and heart failure. It has no role in the prevention or treatment of acute mountain sickness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diltiazem:&nbsp;</strong>Diltiazem is a calcium channel blocker used for treating hypertension and angina. It is not used in the management of acute mountain sickness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetazolamide is the drug of choice for acute mountain sickness because it induces metabolic acidosis and stimulates hyperventilation, helping to improve oxygenation and reduce cerebral edema.</span></p>",
    "correct_choice_id": 27755,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6948,
    "choices": [
      {
        "id": 27760,
        "text": "<p><span style=\"font-size:12.0pt;\">Ethambutol</span></p>"
      },
      {
        "id": 27761,
        "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid</span></p>"
      },
      {
        "id": 27762,
        "text": "<p><span style=\"font-size:12.0pt;\">Kanamycin</span></p>"
      },
      {
        "id": 27763,
        "text": "<p><span style=\"font-size:12.0pt;\">Rifampin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-tubercular drugs is associated with ophthalmic toxicity?</span></p>",
    "unique_key": "Q6080371",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305607,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Ethambutol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethambutol is a first-line anti-tubercular drug used in combination with other medications to treat tuberculosis. One of its significant side effects is ophthalmic toxicity, specifically optic neuritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethambutol inhibits the enzyme arabinosyl transferase, which is necessary for the synthesis of the mycobacterial cell wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ophthalmic Toxicity:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Optic Neuritis:&nbsp;</strong>Ethambutol can cause inflammation of the optic nerve, leading to vision problems.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Symptoms:&nbsp;</strong>Patients may experience blurred vision, loss of visual acuity, and difficulty distinguishing between red and green colors (red-green color blindness).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Monitoring:&nbsp;</strong>It is crucial to monitor visual acuity and color vision regularly in patients taking ethambutol. Any signs of visual impairment should prompt immediate cessation of the drug and consultation with an ophthalmologist.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Isoniazid:&nbsp;</strong>Isoniazid is another first-line anti-tubercular drug. Its main side effects include hepatotoxicity and peripheral neuropathy, but it is not commonly associated with ophthalmic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Kanamycin:&nbsp;</strong>Kanamycin is an aminoglycoside antibiotic used as a second-line treatment for multidrug-resistant tuberculosis (MDR-TB). It is associated with ototoxicity (hearing loss) and nephrotoxicity, not ophthalmic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rifampin:&nbsp;</strong>Rifampin is a first-line anti-tubercular drug that can cause hepatotoxicity and discoloration of bodily fluids (e.g., urine, tears) to an orange-red color. It is not typically associated with ophthalmic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethambutol is a first line anti tubercular drug that can cause optic neuritis and red green color blindness.</span></p>",
    "correct_choice_id": 27760,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6949,
    "choices": [
      {
        "id": 27764,
        "text": "<p><span style=\"font-size:12.0pt;\">Beta blocker</span></p>"
      },
      {
        "id": 27765,
        "text": "<p><span style=\"font-size:12.0pt;\">Alpha agonist</span></p>"
      },
      {
        "id": 27766,
        "text": "<p><span style=\"font-size:12.0pt;\">Pilocarpine</span></p>"
      },
      {
        "id": 27767,
        "text": "<p><span style=\"font-size:12.0pt;\">Prostaglandin analogues</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient with diabetic macular edema developed glaucoma. Which of the following drugs would you consider giving last?</span></p>",
    "unique_key": "Q3209131",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305608,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Prostaglandin analogues</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prostaglandin analogues are effective drugs for reducing intraocular pressure in glaucoma patients by increasing the outflow of aqueous humor through the uveoscleral pathway. However, they can also cause side effects that might exacerbate conditions like macular edema, which is a consideration in this patient who has diabetic macular edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Side Effects of Prostaglandin Analogues:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Cystoid Macular Edema:&nbsp;</strong>This is a known side effect of prostaglandin analogues and can worsen the existing macular edema in a diabetic patient.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Iris Hyperpigmentation:&nbsp;</strong>This is generally a cosmetic issue but can be a concern for some patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hypertrichosis:&nbsp;</strong>This involves increased growth of eyelashes, which is usually considered a benign side effect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the risk of exacerbating macular edema, prostaglandin analogues should be considered last in the treatment plan for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Beta Blockers:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mechanism:&nbsp;</strong>Beta blockers like timolol reduce intraocular pressure by decreasing the production of aqueous humor.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Side Effects:&nbsp;</strong>They are generally well-tolerated in glaucoma treatment and do not exacerbate macular edema. Common side effects include bradycardia and bronchospasm, especially in patients with pre-existing respiratory conditions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Alpha agonist:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mechanism:&nbsp;</strong>Alpha agonists such as brimonidine reduce aqueous humor production and increase uveoscleral outflow.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Side Effects:&nbsp;</strong>These drugs can cause dry mouth, fatigue, and ocular allergies, but they do not significantly affect macular edema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pilocarpine:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mechanism:&nbsp;</strong>Pilocarpine is a miotic agent that increases aqueous humor outflow through the trabecular meshwork.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Side Effects:&nbsp;</strong>It can cause miosis, accommodative spasm, and brow ache. Pilocarpine does not exacerbate macular edema but is less commonly used due to its side effect profile and the need for frequent dosing.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cystoid Macular edema is one of the side effects of Prostaglandin analogues. The other side effects are Iris hyperpigmentation and hypertrichosis of the eye lashes.</span></p>",
    "correct_choice_id": 27767,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6950,
    "choices": [
      {
        "id": 27768,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Delayed diastolic depolarization</span></span></span></p>"
      },
      {
        "id": 27769,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase in plateau</span></span></span></p>"
      },
      {
        "id": 27770,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in preload</span></span></span></p>"
      },
      {
        "id": 27771,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase in afterload</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the mechanism by which acetylcholine causes a decrease in the heart rate?</span></span></p>",
    "unique_key": "Q9293678",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305609,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Delayed diastolic depolarization</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acetylcholine decreases heart rate by acting on muscarinic M2 receptors present in the sinoatrial (SA) node of the heart. The key mechanism involves:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Activation of M2 Receptors:&nbsp;</span></strong><span style=\"font-size:12.0pt\">When acetylcholine binds to M2 receptors, it activates a G-protein coupled pathway.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Opening of Potassium Channels:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This leads to the opening of specific potassium channels (GIRK channels) resulting in an increased efflux of potassium ions from the SA node cells.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hyperpolarization:&nbsp;</span></strong><span style=\"font-size:12.0pt\">The efflux of potassium causes hyperpolarization of the cell membrane, making it more negative.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Delayed Diastolic Depolarization:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This hyperpolarization delays the diastolic depolarization phase, slowing the rate at which the SA node reaches the threshold potential to initiate the next action potential.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Result:&nbsp;</span></strong><span style=\"font-size:12.0pt\">The overall effect is a reduction in the heart rate (negative chronotropy).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increase in Plateau:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism:&nbsp;</span></strong><span style=\"font-size:12.0pt\">An increase in the plateau phase would generally refer to the action of calcium channels during the action potential of myocardial cells, not the SA node. This mechanism is more related to the contractile cells rather than pacemaker cells.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Effect:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This does not directly influence heart rate but can affect the force of contraction.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Decrease in Preload:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Preload refers to the end-diastolic volume in the ventricles. While changes in preload can influence stroke volume and cardiac output, they are not directly related to the rate control mechanisms mediated by acetylcholine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Increase in Afterload:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Afterload refers to the resistance the heart must pump against, primarily influenced by systemic vascular resistance. This is not directly influenced by acetylcholine&#39;s action on the SA node and does not explain the decrease in heart rate.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The acetylcholine acts on the M2 receptor present on the SA node. This opens a special set of potassium channels causing an efflux of potassium (kAch) which hyperpolarizes the SA node. This leads to delayed depolarization of the SA node during ventricular diastole, thus leading to a slow heart rate.</span></span></span></p>",
    "correct_choice_id": 27768,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6951,
    "choices": [
      {
        "id": 27772,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in Vmax</span></span></span></p>"
      },
      {
        "id": 27773,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in Km</span></span></span></p>"
      },
      {
        "id": 27774,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in both Km and Vmax</span></span></span></p>"
      },
      {
        "id": 27775,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No change in Vmax</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diamox is given to a patient with glaucoma. It is a non-competitive inhibitor of the carbonic anhydrase enzyme. Which of the following would be the effect of this drug?</span></span></span></p>",
    "unique_key": "Q2079416",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305610,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Decrease in Vmax</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diamox (acetazolamide) is a non-competitive inhibitor of the enzyme carbonic anhydrase. The effects of a non-competitive inhibitor on enzyme kinetics are distinct:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Non-competitive Inhibition:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This type of inhibition occurs when the inhibitor binds to an enzyme at a site other than the active site. This binding can occur whether or not the substrate has bound to the enzyme.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Vmax Decrease:&nbsp;</span></strong><span style=\"font-size:12.0pt\">The non-competitive inhibitor reduces the maximum rate of the reaction (Vmax) because it affects the enzyme&#39;s catalytic function. This means that even with a high substrate concentration, the enzyme cannot achieve the same Vmax as it would without the inhibitor.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Km Unchanged:&nbsp;</span></strong><span style=\"font-size:12.0pt\">The affinity of the enzyme for the substrate, represented by Km, remains unchanged because the inhibitor does not interfere with the binding of the substrate to the enzyme. The substrate can still bind to the enzyme with the same affinity, but the enzyme-inhibitor complex cannot form the product at the same rate as the enzyme alone.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-1.jpg\" style=\"height:356px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Decrease in Km: Explanation:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This would be expected in the case of a competitive inhibitor, which increases the substrate concentration needed to achieve half of Vmax, effectively increasing Km. Non-competitive inhibition does not change Km.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Decrease in both Km and Vmax: Explanation:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Non-competitive inhibitors do not affect Km because they do not interfere with substrate binding directly. They only reduce the catalytic activity, hence only Vmax is decreased.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. No change in Vmax: Explanation:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect for non-competitive inhibitors, which specifically lower Vmax due to the reduced number of active enzyme molecules available for the reaction.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diamox, as a non-competitive inhibitor of carbonic anhydrase, decreases the maximum velocity (Vmax) of the enzyme-catalyzed reaction without changing the Michaelis constant (Km). This inhibition reduces the enzyme&#39;s catalytic activity but does not alter its substrate binding affinity.</span></span></span></p>",
    "correct_choice_id": 27772,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6954,
    "choices": [
      {
        "id": 27784,
        "text": "<p><span style=\"font-size:12.0pt;\">Low t 1/2</span></p>"
      },
      {
        "id": 27785,
        "text": "<p><span style=\"font-size:12.0pt;\">Low bioavailability</span></p>"
      },
      {
        "id": 27786,
        "text": "<p><span style=\"font-size:12.0pt;\">Low efficacy</span></p>"
      },
      {
        "id": 27787,
        "text": "<p><span style=\"font-size:12.0pt;\">Not extensively distributed to tissues</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Low apparent volume of distribution of drug indicates?</span></p>",
    "unique_key": "Q5797644",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305611,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Not extensively distributed to tissues</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Apparent Volume of distribution (Vd) = dose administered I.V/ plasma concentration It indicates how extensively the drug is distributed in the tissues. For example, Chloroquine has the highest volume of distribution, as it is mostly distributed to the liver and a very small amount is left for the action on RBC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">E.g.: If a 1000 mg of drug A is given i.v (100% bioavailability) and the plasma concentration reached is 10 mg/ liter then the apparent volume of distribution (Vd) is 1000/10= 10 liters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">But the normal blood volume is about 5 liters. A high Vd is due to accumulation of drug A being distributed in extravascular tissues resulting in low plasma concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Half-life or t1/2 relationship with volume of distribution (Vd) and clearance (CI) is given by the formula t 1/2 = 0.693 \u00d7 Vd /CI. t1/2 is directly proportional to Vd but it is also inversely proportional to clearance. If a drug has a low volume of distribution but clearance is very low, t1/2 can still be high. So low Vd doesn't always imply low t1/2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Low t 1/2:&nbsp;</strong>The half-life (t1/2) of a drug is influenced by both its volume of distribution (Vd) and its clearance (Cl). It is given by the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">t1/2=0.693\u00d7Vd/Cl</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A low Vd does not necessarily imply a low half-life, as the half-life is also dependent on the clearance of the drug. If the clearance is low, the half-life can still be long despite a low Vd.</span></p><p style=\"margin-left:40px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Low bioavailability:&nbsp;</strong>Bioavailability refers to the fraction of an administered dose of a drug that reaches the systemic circulation in an unchanged form. It is primarily affected by the route of administration and first-pass metabolism, not by the volume of distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Low efficacy:&nbsp;</strong>Efficacy refers to the ability of a drug to produce a desired therapeutic effect. It is determined by the drug\u2019s mechanism of action and intrinsic activity at its target receptors, not by its volume of distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A low apparent volume of distribution (Vd) indicates that the drug is not extensively distributed to tissues and remains largely confined to the blood plasma. This parameter is essential for understanding the pharmacokinetic behavior of the drug in the body.</span></p>",
    "correct_choice_id": 27787,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30507,
    "choices": [
      {
        "id": 121906,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metoprolol</span></span></span></p>"
      },
      {
        "id": 121907,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trimetazidine</span></span></span></p>"
      },
      {
        "id": 121908,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sacubitril</span></span></span></p>"
      },
      {
        "id": 121909,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nesiritide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Which</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"> of the following drugs is not used in heart failure?</span></span></span></span>(AIIMS NOV 2019)</p>",
    "unique_key": "Q1061825",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305612,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;B. Trimetazidine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trimetazidine is not used in heart failure because it is primarily a metabolic modulator. It partially inhibits the beta-oxidation of fatty acids, which results in shifting the metabolism of heart muscles from fatty acids to glucose. This shift requires less oxygen, making trimetazidine beneficial for patients with angina pectoris. However, it does not have a role in the management of heart failure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Metoprolol:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Metoprolol is a beta-blocker that is used in the management of chronic heart failure. Beta-blockers are contraindicated in acute heart failure but can be beneficial in chronic heart failure when started at a low dose and gradually increased to avoid decompensation. The beta-blockers commonly used in heart failure include carvedilol, metoprolol, and bisoprolol.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sacubitril:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Sacubitril is an NEP (neutral endopeptidase) inhibitor, which prevents the breakdown of brain natriuretic peptide (BNP). By inhibiting NEP, sacubitril increases BNP levels, leading to natriuresis and vasodilation, which are beneficial effects in chronic heart failure (CHF). Therefore, sacubitril is used in the treatment of CHF.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nesiritide:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Nesiritide is a recombinant form of BNP and is administered through the subcutaneous route. It helps to induce natriuresis and vasodilation, thus can be used in the treatment of heart failure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trimetazidine, although beneficial for angina pectoris due to its metabolic modulation properties, is not used in the treatment of heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Note - </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Beta blockers are contraindicated in acute heart failure, but they can be used in chronic heart failure. Beta blockers should be started at low dose, dose should be increased gradually to prevent decompensation. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Beta blockers used are</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">&nbsp;&ndash; Carvedilol, metoprolol and bisoprolol.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/ 599, 600</span></span></strong></span></span></p>",
    "correct_choice_id": 121907,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6956,
    "choices": [
      {
        "id": 27792,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cardiac defects</span></span></span></p>"
      },
      {
        "id": 27793,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Facial defects</span></span></span></p>"
      },
      {
        "id": 27794,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CNS defects</span></span></span></p>"
      },
      {
        "id": 27795,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urogenital defects</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium usage in pregnancy can lead to which of the following teratogenic effects?</span></span></p>",
    "unique_key": "Q6780365",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305613,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Cardiac defects</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lithium is a mood stabilizer commonly used in the treatment of bipolar disorder. However, its use during pregnancy is associated with an increased risk of congenital cardiac defects, particularly Ebstein&#39;s anomaly.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ebstein&#39;s Anomaly</span></strong><span style=\"font-size:12.0pt\"> is a rare heart defect characterized by:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malformation of the tricuspid valve</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Downward displacement of the valve into the right ventricle</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abnormal development of the right ventricle leading to its partial arterialization</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This condition results in a &quot;box-shaped&quot; heart appearance on radiographic imaging. Because of this risk, the use of lithium during pregnancy, especially during the first trimester, is generally avoided unless absolutely necessary.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Facial defects:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While certain medications and teratogens can cause facial defects, lithium is not primarily associated with facial anomalies. Drugs like isotretinoin are more commonly linked to facial defects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. CNS defects:&nbsp;</span></strong><span style=\"font-size:12.0pt\">CNS defects can be caused by various teratogens, but lithium is not specifically known to cause central nervous system malformations. Antiepileptic drugs like valproate have a higher association with CNS defects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Urogenital defects:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lithium is not commonly associated with urogenital defects. These defects can be caused by other teratogens and genetic factors but are not linked to lithium usage.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lithium is teratogenic in pregnancy as it can give rise to Ebstein&rsquo;s anomaly. It is characterized by arterialization of the right ventricle, giving rise to a box-shaped heart when seen radiologically.</span></span></span></p>",
    "correct_choice_id": 27792,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30509,
    "choices": [
      {
        "id": 121914,
        "text": "<p><span style=\"font-size:12.0pt;\">2 drugs for 6 months</span></p>"
      },
      {
        "id": 121915,
        "text": "<p><span style=\"font-size:12.0pt;\">2 drugs for 12 months</span></p>"
      },
      {
        "id": 121916,
        "text": "<p><span style=\"font-size:12.0pt;\">3 drugs for 6 months</span></p>"
      },
      {
        "id": 121917,
        "text": "<p><span style=\"font-size:12.0pt;\">3 drugs for 12 months</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">Which of the following is used for the treatment of paucibacillary leprosy?&nbsp;</span>(AIIMS NOV 2019)</p>",
    "unique_key": "Q3105089",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305614,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. C. 3 drugs for 6 months</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">According to the latest WHO guidelines treatment of multibacillary and paucibacillary leprosy is same except for duration of treatment.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-190658.jpg\" alt=\"\" width=\"1000\" height=\"262\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment for paucibacillary leprosy involves a combination of three drugs (rifampin, clofazimine, and dapsone) administered over a period of 6 months.</span></p>",
    "correct_choice_id": 121916,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30510,
    "choices": [
      {
        "id": 121918,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Neostigmine</span></span></span></p>"
      },
      {
        "id": 121919,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine</span></span></span></p>"
      },
      {
        "id": 121920,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flumazenil</span></span></span></p>"
      },
      {
        "id": 121921,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physostigmine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented to emergency with overdose some drug. There were increased salivation and increased bronchial secretions. On examination, blood pressure was 88/60 mmHg. RBC esterase level is 50. What should be the treatment of this person?</span></span>(AIIMS NOV 2019)</p>",
    "unique_key": "Q7624709",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305615,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. B. Atropine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Low esterase levels are suggestive of overdose of some drug which acts by inhibiting acetyl choline esterase like organophosphate poisoning.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Inhibition of choline esterase results in increased amount of Ach at synapse, so poisoning or overdose results in cholinergic symptoms like salivation, lacrimation, urination, emesis, increased bronchial secretions, and reduction in blood pressure.<br />\r\n\tSo treatment of choice is Atropine.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Atropine - It is highly effective in counter-acting the muscarinic symptoms, but higher doses are required to antagonize the central effects. It does not reverse peripheral muscular paralysis which is a nicotinic action. All cases of anti-ChE (carbamate or organophosphate) poisoning must be promptly treated with atropine 2 mg i.v. repeated every 10 min till dryness of mouth or other signs of atropinization appear (upto 200 mg has been administered in a day). Continued treatment with maintenance doses may be required for 1-2 weeks.</span></span></span></span></li>\r\n</ul>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Neostigmine:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine is incorrect as it is an acetylcholine esterase inhibitor, which would worsen the cholinergic symptoms by increasing acetylcholine levels further.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Flumazenil:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flumazenil is incorrect because it is an antidote for benzodiazepine overdose, not for organophosphate poisoning. It works by antagonizing the effects of benzodiazepines on the central nervous system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Physostigmine:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine is incorrect as it is also an acetylcholine esterase inhibitor, which would exacerbate the </span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">symptoms of cholinergic overdose. Additionally, it is used to treat atropine poisoning, not organophosphate poisoning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of organophosphate poisoning, which presents with cholinergic symptoms and low RBC esterase levels, the treatment of choice is atropine, administered intravenously until signs of atropinization appear.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/122</span></span></strong></span></span></p>",
    "correct_choice_id": 121919,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30511,
    "choices": [
      {
        "id": 121922,
        "text": "<p><span style=\"font-size:12.0pt;\">Organophosphates</span></p>"
      },
      {
        "id": 121923,
        "text": "<p><span style=\"font-size:12.0pt;\">Belladonna</span></p>"
      },
      {
        "id": 121924,
        "text": "<p><span style=\"font-size:12.0pt;\">Morphine</span></p>"
      },
      {
        "id": 121925,
        "text": "<p><span style=\"font-size:12.0pt;\">Pilocarpine</span></p>"
      }
    ],
    "text": "<p><span style=\"color:#333333;font-size:12pt;\">All&nbsp;of the following can cause miosis except</span></p>",
    "unique_key": "Q8742298",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305616,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. B. Belladonna</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">Belladonna is plant (Atropa belladonna) from which atropine (Anticholinergic drug) is obtained. It causes mydriasis not miosis.</span></p><p>&nbsp;</p><h3><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></h3><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Organophosphates:&nbsp;</strong>Organophosphates cause miosis by inhibiting acetylcholinesterase, which increases acetylcholine levels, resulting in overstimulation of muscarinic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Morphine:&nbsp;</strong>Morphine induces miosis by stimulating the parasympathetic nervous system through opioid receptors, leading to pupil constriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Pilocarpine:&nbsp;</strong>Pilocarpine is a cholinergic drug that causes miosis by directly activating muscarinic receptors in the eye.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Miosis or pin point pupil is caused by:-</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">Organophosphate poisoning</span></li><li><span style=\"color:#333333;font-size:12pt;\">Opioids like morphine</span></li><li><span style=\"color:#333333;font-size:12pt;\">Phenol poisoning</span></li><li><span style=\"color:#333333;font-size:12pt;\">Pontine hemorrhage</span></li><li><span style=\"color:#333333;font-size:12pt;\">Cholinergic drugs like pilocarpine</span></li></ul><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8<sup>th</sup>/115,122,127,499</strong></span></p>",
    "correct_choice_id": 121923,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30512,
    "choices": [
      {
        "id": 121926,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To allay anxiety</span></span></span></p>"
      },
      {
        "id": 121927,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To decrease secretions</span></span></span></p>"
      },
      {
        "id": 121928,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As inducing agent</span></span></span></p>"
      },
      {
        "id": 121929,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For muscle relaxation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A patient was schedule for surgery. Before giving anaesthesia, he was administered glycopyrrolate. What is rationale of giving glycopyrrolate before anaesthesia?</span></span></span></span>(AIIMS NOV 2019)</p>",
    "unique_key": "Q6676221",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305617,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. B. To decrease secretions</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Preanesthetic medication refers to the use of drugs before anaesthesia to make it safe and less unpleasant.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">When inhalation anaesthetic agents are given, they inhibit the ciliary function resulting in accumulation of secretions in the respiratory pathway. Therefore anti-cholinergic drugs like atropine or glycopyrrolate are used as pre-anaesthetic medication for their anti-secretory action.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Glycopyrrolate is twice as potent and longer acting quaternary anti-muscarinic which does not produce central effects. Anti-secretory action is more marked than atropine and tachycardia is less marked. It acts rapidly when given i.v. and is the preferred anti-muscarinic in anaesthetic practice.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. To allay anxiety:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Glycopyrrolate is not used to allay anxiety. Anxiolytics such as benzodiazepines are typically used for this purpose.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. As inducing agent:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Glycopyrrolate is not an inducing agent. Inducing agents are drugs like propofol or thiopental used to induce anaesthesia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. For muscle relaxation:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Glycopyrrolate is not used for muscle relaxation. Muscle relaxants like vecuronium or succinylcholine are used for this purpose during surgical procedures.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glycopyrrolate is administered before anaesthesia to decrease respiratory secretions, making the anaesthetic procedure safer and more efficient by preventing the accumulation of secretions that can interfere with the airway during surgery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/. 413,414</span></span></strong></span></span></p>",
    "correct_choice_id": 121927,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6955,
    "choices": [
      {
        "id": 27788,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ampicillin</span></span></span></p>"
      },
      {
        "id": 27789,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Co-trimoxazole</span></span></span></p>"
      },
      {
        "id": 27790,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Azithromycin</span></span></span></p>"
      },
      {
        "id": 27791,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chloramphenicol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An infant of 2 months had a serum bilirubin level of 33 mg/dL. The mother might have taken which of the following drugs during the third trimester for this to occur?&nbsp;&nbsp;&nbsp;&nbsp;</span></span></p>",
    "unique_key": "Q9759540",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305618,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Co-trimoxazole</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Co-trimoxazole is a combination of two antibiotics: trimethoprim and sulfamethoxazole. Sulfamethoxazole is a sulfonamide, which can displace bilirubin from its binding sites on plasma albumin. This displacement increases the free bilirubin levels in the blood, which can cross the blood-brain barrier and potentially lead to kernicterus, a type of brain damage resulting from very high levels of bilirubin in a newborn&#39;s blood.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When pregnant women take sulfonamides near term, these drugs can cross the placenta and affect the fetus, increasing the risk of hyperbilirubinemia and kernicterus in newborns. Therefore, Co-trimoxazole is contraindicated during the third trimester of pregnancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ampicillin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Ampicillin is a penicillin antibiotic. It does not displace bilirubin from albumin, and therefore, it is not associated with an increased risk of hyperbilirubinemia or kernicterus in newborns.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Azithromycin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Azithromycin is a macrolide antibiotic. It is not known to displace bilirubin from albumin and is not associated with an increased risk of hyperbilirubinemia or kernicterus in newborns.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chloramphenicol:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Chloramphenicol is an antibiotic that can cause gray baby syndrome when given to newborns due to their immature liver enzymes, but it does not typically cause hyperbilirubinemia or kernicterus. It is not known to displace bilirubin from albumin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Co-trimoxazole, which contains the sulfonamide sulfamethoxazole, can displace bilirubin from plasma albumin, increasing the risk of hyperbilirubinemia and kernicterus in newborns. Therefore, it is contraindicated during the third trimester of pregnancy or during lactation.</span></span></span></p>",
    "correct_choice_id": 27789,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6891,
    "choices": [
      {
        "id": 27532,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methotrexate</span></span></span></p>"
      },
      {
        "id": 27533,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lefunamide</span></span></span></p>"
      },
      {
        "id": 27534,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sulphasalazine</span></span></span></p>"
      },
      {
        "id": 27535,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydroxychloroquine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anti rheumatoid drug increases extracellular adenosine? (</span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q2897755",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305619,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Methotrexate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methotrexate works primarily by inhibiting AICAR transformylase and thymidylate synthetase.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">AICAR accumulates intracellularly and competes with AMP deaminase, resulting in AMP accumulation. AMP is released and converted extracellularly to adenosine, which is acts as the powerful anti-inflammatory agent. As a result, neutrophils, macrophages, dendritic cells, and lymphocytes&#39; inflammatory functions are suppressed.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Leflunomide:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Leflunomide inhibits dihydroorotate dehydrogenase, which is involved in the de novo synthesis of pyrimidines, thereby suppressing the proliferation of activated lymphocytes. It does not increase extracellular adenosine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sulphasalazine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Sulphasalazine is a prodrug that is metabolized into sulfapyridine and 5-aminosalicylic acid (5-ASA). Its anti-inflammatory effects are primarily due to the action of 5-ASA. It does not increase extracellular adenosine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hydroxychloroquine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Hydroxychloroquine is thought to exert its anti-inflammatory effects by interfering with lysosomal activity and autophagy in immune cells, and by modulating the activity of toll-like receptors (TLRs). It does not increase extracellular adenosine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methotrexate increases extracellular adenosine by inhibiting AICAR transformylase, leading to the accumulation of AICAR, which competes with AMP deaminase and causes AMP to accumulate and be converted to adenosine outside the cell, thus exerting anti-inflammatory effects.</span></span></span></p>",
    "correct_choice_id": 27532,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6994,
    "choices": [
      {
        "id": 27944,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unfractionated Heparin</span></span></span></p>"
      },
      {
        "id": 27945,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Warfarin</span></span></span></p>"
      },
      {
        "id": 27946,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low molecular weight heparin</span></span></span></p>"
      },
      {
        "id": 27947,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dabigatran</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which is the anticoagulant of choice for the management of cancer-associated thromboembolism? (AIIMS MAY 2018)</span></span></span></p>",
    "unique_key": "Q5165181",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305620,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Low molecular weight heparin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMWH is the anticoagulant of choice for the treatment of Cancer associated thromboembolism. It has a long half-life, higher bioavailability and does not require anticoagulant monitoring.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Unfractionated Heparin</span></strong><span style=\"font-size:12.0pt\">: While effective, it requires continuous intravenous infusion and frequent monitoring of activated partial thromboplastin time (aPTT), making it less convenient for long-term management.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Warfarin</span></strong><span style=\"font-size:12.0pt\">: Warfarin requires regular monitoring of the international normalized ratio (INR) to maintain therapeutic levels, which can be challenging in cancer patients due to potential drug interactions and varying dietary intake.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Dabigatran</span></strong><span style=\"font-size:12.0pt\">: Dabigatran is an oral direct thrombin inhibitor. Although effective, it is not the first choice for cancer-associated thromboembolism due to limited evidence compared to LMWH and potential for drug interactions and gastrointestinal side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Low molecular weight heparin (LMWH) is the preferred anticoagulant for managing cancer-associated thromboembolism due to its long half-life, higher bioavailability, and the convenience of not requiring routine anticoagulant monitoring.</span></span></span></p>",
    "correct_choice_id": 27946,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6995,
    "choices": [
      {
        "id": 27948,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Edaravone</span></span></span></p>"
      },
      {
        "id": 27949,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Piracetam</span></span></span></p>"
      },
      {
        "id": 27950,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dabrafenib</span></span></span></p>"
      },
      {
        "id": 27951,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trametinib</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following new drugs has been approved for the treatment of amyotrophic lateral sclerosis? (</span></span>AIIMS May 2018)</p>",
    "unique_key": "Q8243815",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305621,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Edaravone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Edaravone is an FDA approved drug used in the treatment of Amyotrophic Lateral Sclerosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It has free radical scavenging properties that may reduce oxidative stress although the exact mechanism of action is unknown. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Piracetam</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Piracetam is used off-label for cognitive enhancement and the treatment of myoclonus. It is not approved for the treatment of ALS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dabrafenib</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Dabrafenib is a targeted therapy used for the treatment of BRAF V600E mutation-positive melanoma. It is not used for ALS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trametinib</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Trametinib is also used for the treatment of BRAF V600E mutation-positive melanoma. It is not indicated for ALS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Edaravone is the new drug approved for the treatment of amyotrophic lateral sclerosis (ALS), primarily due to its free radical scavenging properties that may help reduce oxidative stress, a factor involved in the disease&#39;s progression.</span></span></span></p>",
    "correct_choice_id": 27948,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6996,
    "choices": [
      {
        "id": 27952,
        "text": "<p><span style=\"font-size:12.0pt;\">Chloramphenicol, doxycycline</span></p>"
      },
      {
        "id": 27953,
        "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline, doxycycline</span></p>"
      },
      {
        "id": 27954,
        "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline, azithromycin</span></p>"
      },
      {
        "id": 27955,
        "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin, doxycycline</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the drug of choice for scrub typhus during pregnancy and otherwise respectively? (</span>AIIMS May 2018)</p>",
    "unique_key": "Q8826752",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305622,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Azithromycin, doxycycline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The DOC for scrub typhus is Doxycycline, but it cannot be used during pregnancy as it can lead to bone growth abnormality in the newborn. So, in that case, to treat Scrub Typhus in Pregnancy, we use Azithromycin.</span></p><p>&nbsp;</p><h3><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></h3><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Chloramphenicol, doxycycline</strong>: Chloramphenicol is not the first-line treatment for scrub typhus, and doxycycline is indeed used for non-pregnant individuals, but this pair does not cover the correct alternatives during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Doxycycline, doxycycline</strong>: This option does not address the contraindication of doxycycline during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Doxycycline, azithromycin</strong>: This reverses the correct pair; azithromycin is used during pregnancy, not doxycycline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The drug of choice for treating scrub typhus in pregnant women is azithromycin, while doxycycline is used for non-pregnant individuals.</span></p>",
    "correct_choice_id": 27955,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6997,
    "choices": [
      {
        "id": 27956,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscarinic</span></span></span></p>"
      },
      {
        "id": 27957,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nicotinic</span></span></span></p>"
      },
      {
        "id": 27958,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GABA-A</span></span></span></p>"
      },
      {
        "id": 27959,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an example of a GPCR? (</span></span>AIIMS May 2018)</p>",
    "unique_key": "Q2095126",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305623,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Muscarinic</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscarinic receptors are G-protein-coupled receptors. Out of them, M1 and M3 act through Gq pathway and via the IP3/DAG pathway, whereas M2 and M4 act via Gi protein, that inhibits adenylyl cyclase leading to a decrease in the levels of cAMP.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotinic</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nicotinic receptors are ionotropic receptors, which means they are ion channel receptors and not GPCRs. They allow the passage of ions across the cell membrane when activated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GABA-A</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: GABA-A receptors are also ionotropic receptors that function as chloride ion channels. They are not GPCRs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The insulin receptor is a receptor tyrosine kinase (RTK), not a GPCR. It initiates a cascade of intracellular signaling upon binding insulin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptors are G-protein-coupled receptors (GPCRs) that play a role in various physiological processes through different G-protein signaling pathways.</span></span></span></p>",
    "correct_choice_id": 27956,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6998,
    "choices": [
      {
        "id": 27960,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spurious drug</span></span></span></p>"
      },
      {
        "id": 27961,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adulterated drug</span></span></span></p>"
      },
      {
        "id": 27962,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unethical drug</span></span></span></p>"
      },
      {
        "id": 27963,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Misbranded drug</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The manufacturer of a drug company labels a drug as having 500 mg paracetamol. On quantitative analysis of the drug, it actually contained only 200 mg of paracetamol. What is this type of drug called? (</span></span></span>AIIMS May 2018)</p>",
    "unique_key": "Q8280428",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305624,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Misbranded drug</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A drug stating that 500mg of paracetamol is present in each tablet, but contains only 200mg is a misbranded drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A misbranded drug will not produce the effect due to reasons like lesser dose, different molecules in it etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Spurious drugs:</strong> are drugs with improper labelling, labeling from a fictitious company, with improper storage guidelines, or even partly or wholly substituted by another drug or substance.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Adulterated drugs:</strong> are drugs with unwanted substance, for example iron in Paracetamol.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.&nbsp;unethical drug:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The term unethical drug is not used. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A drug that is labeled as containing a certain amount of an active ingredient but actually contains a different amount is considered misbranded. Misbranded drugs can lead to ineffective treatment and potential harm due to incorrect dosing.</span></span></span></p>",
    "correct_choice_id": 27963,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6999,
    "choices": [
      {
        "id": 27964,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine</span></span></span></p>"
      },
      {
        "id": 27965,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ranitidine</span></span></span></p>"
      },
      {
        "id": 27966,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metoclopramide</span></span></span></p>"
      },
      {
        "id": 27967,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Domperidone</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented to the casualty with signs of dehydration due to severe vomiting.<strong> </strong>The intern gave the patient a parenteral medication, following which the patient developed grimacing and abnormal posturing. What could have been the inciting drug for this reaction? (</span></span>AIIMS May 2018)</p>",
    "unique_key": "Q4673929",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305625,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Metoclopramide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metoclopramide is an anti-emetic that acts by blocking the D2 receptors. It can cross the blood brain barrier and can lead to Dopaminergic blockade in the various parts of the brain leading to Acute dystonia, drowsiness, abnormal posturing, Parkinsonism etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Domperidone is also a D2 Receptor blocker, but cannot cross the BBB, therefore it does not produce such side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Atropine is an anticholinergic drug that does not typically cause extrapyramidal side effects. It is used to reduce salivation and bronchial secretions and to treat bradycardia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ranitidine</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ranitidine is an H2 receptor antagonist used to reduce stomach acid production. It does not have significant central nervous system effects or cause extrapyramidal symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Domperidone</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Domperidone is also a dopamine D2 receptor blocker used as an anti-emetic. However, it does not cross the blood-brain barrier effectively and therefore does not typically cause central nervous system side effects like metoclopramide.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoclopramide, an anti-emetic that blocks D2 receptors and crosses the blood-brain barrier, can cause extrapyramidal side effects such as acute dystonia, drowsiness, abnormal posturing, and Parkinsonism-like symptoms.</span></span></span></p>",
    "correct_choice_id": 27966,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7000,
    "choices": [
      {
        "id": 27968,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ketoconazole: Lanosterol-14-demethylase inhibition</span></span></span></p>"
      },
      {
        "id": 27969,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flucytosine: Inhibits microtubule synthesis and thus hinders mitosis</span></span></span></p>"
      },
      {
        "id": 27970,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Terbinafine: Squalene epoxidase inhibition</span></span></span></p>"
      },
      {
        "id": 27971,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amphotericin B: Sequesters ergosterol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the wrongly matched pair of antifungals with its mechanism of action? (</span></span></span>AIIMS May 2018)</p>",
    "unique_key": "Q7408436",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305626,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Flucytosine: Inhibits microtubule synthesis and thus hinders mitosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All of the above Antifungal agents are correctly matched with their corresponding mechanisms of action except for Flucytosine. Flucytosine acts by inhibiting the synthesis of nucleic acid. Griseofulvin is the antifungal that acts by inhibiting microtubule synthesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketoconazole: Lanosterol-14-demethylase inhibition</span></strong></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketoconazole is correctly matched. It inhibits lanosterol-14-demethylase, an enzyme involved in the biosynthesis of ergosterol, which is a crucial component of the fungal cell membrane.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terbinafine: Squalene epoxidase inhibition</span></strong></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terbinafine is correctly matched. It inhibits squalene epoxidase, an enzyme involved in the biosynthesis of ergosterol, leading to the accumulation of toxic levels of squalene and cell death.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amphotericin B: Sequesters ergosterol</span></strong></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amphotericin B is correctly matched. It binds to ergosterol in the fungal cell membrane, creating pores that increase membrane permeability and cause cell contents to leak out, leading to cell death.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flucytosine inhibits nucleic acid synthesis, not microtubule synthesis. The correct antifungal that inhibits microtubule synthesis is griseofulvin.</span></span></span></p>",
    "correct_choice_id": 27969,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7001,
    "choices": [
      {
        "id": 27972,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tmax</span></span></span></p>"
      },
      {
        "id": 27973,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cmax</span></span></span></p>"
      },
      {
        "id": 27974,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">T1/2</span></span></span></p>"
      },
      {
        "id": 27975,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Area under the curve</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following parameters is used to assess the extent of drug absorption in a plasma concentration vs. time graph? (</span></span>AIIMS May 2018)</p>",
    "unique_key": "Q1373740",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305627,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Area under the curve</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the Concentration-time curve for a given drug, the area under the curve (AUC) tells us about the bioavailability of the drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The bioavailability of a given drug is defined as the fraction of the given dose that reaches the systemic circulation. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It depends on 2 factors:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1.Absorption of the drug (More the extent of absorption of the drug, greater is the bioavailability)</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2.First pass metabolism of the drug (More the first pass metabolism of a drug, lesser is its bioavailability).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">So, in other words, the AUC tells us about the extent of absorption of the drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tmax</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The time to reach the maximum concentration (Cmax) in plasma. It indicates the rate of absorption but not the extent of absorption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cmax</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The maximum concentration of the drug in plasma. It provides information on the peak level achieved but does not reflect the overall extent of absorption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T1/2</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The half-life of the drug, which is the time it takes for the plasma concentration to reduce by half. This parameter is related to the duration of action and elimination of the drug, not the extent of absorption.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Area Under the Curve (AUC) in a plasma concentration vs. time graph is used to assess the extent of drug absorption, reflecting the bioavailability of the drug in the systemic circulation.</span></span></span></p>",
    "correct_choice_id": 27975,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7002,
    "choices": [
      {
        "id": 27976,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sublingual</span></span></span></p>"
      },
      {
        "id": 27977,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oral</span></span></span></p>"
      },
      {
        "id": 27978,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intravenous</span></span></span></p>"
      },
      {
        "id": 27979,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transdermal</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following routes of administration will not bypass hepatic first-pass metabolism? (</span></span>AIIMS May 2018)</p>",
    "unique_key": "Q8072437",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305628,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Oral</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatic first-pass metabolism refers to the process where the concentration of a drug is greatly reduced before it reaches the systemic circulation. This occurs primarily when drugs are metabolized in the liver after being absorbed. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When a drug is taken orally, it is absorbed through the gastrointestinal tract and then passes through the liver before reaching systemic circulation. This route is subject to significant hepatic first-pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sublingual</span></strong><span style=\"font-size:12.0pt\">: This route involves placing a drug under the tongue, where it is absorbed directly into the bloodstream through the tissues beneath the tongue. It bypasses the liver initially, thus avoiding hepatic first-pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Intravenous (IV)</span></strong><span style=\"font-size:12.0pt\">: Intravenous administration delivers a drug directly into the bloodstream, completely bypassing the liver initially. Therefore, it does not undergo first-pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transdermal</span></strong><span style=\"font-size:12.0pt\">: Transdermal administration involves applying a drug through the skin (e.g., via a patch). The drug is absorbed directly into systemic circulation, bypassing the liver initially and thus avoiding first-pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Please read the question carefully, which does not bypass means which undergoes first pass metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The route of administration that does not bypass hepatic first-pass metabolism is Oral. This is because drugs taken orally are absorbed from the gastrointestinal tract and then pass through the liver where they may be metabolically altered before reaching the systemic circulation.</span></span></span></p>",
    "correct_choice_id": 27977,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7003,
    "choices": [
      {
        "id": 27980,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombin</span></span></span></p>"
      },
      {
        "id": 27981,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Plasmin</span></span></span></p>"
      },
      {
        "id": 27982,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antithrombin-III</span></span></span></p>"
      },
      {
        "id": 27983,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombomodulin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the action of heparin as an anticoagulant, availability of which of the following chemical substances is mandatory? (</span></span>AIIMS May 2018)</p>",
    "unique_key": "Q7229827",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305629,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Antithrombin-III</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Heparin acts indirectly by activating Antithrombin-III. The heparin-antithrombin III then binds to the clotting factors of the intrinsic pathway (10, 2, 9 ,11 and 12) and inactivates them. The anticoagulation action is exerted mainly by the inhibition of factor 10 as well as thrombin or factor 2. Therefore Antithrombin-Ill is mandatory for the action of heparin as an anticoagulant. Reduced antithrombin levels can lead to resistance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In true heparin resistance, there is an actual blunting of heparin&#39;s anticoagulant effect. This occurs due to:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low ATIII levels (most common cause)</span></span></span></li>\r\n\t<li><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased heparin-binding plasma proteins (acute phase reactants)</span></span></span></li>\r\n\t<li><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased heparin clearance (e.g., due to splenomegaly in liver disease)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low ATIII levels could be due to decreased synthesis (hereditary, hepatic failure), increased consumption (DIC, MAHA, or in a bypass circuit) or increased loss (nephrotic syndrome).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The dose of heparin has to be increased to achieve therapeutic aPTT. Severe antithrombin deficiency may require antithrombin concentrate as well.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Thrombin is a target of the heparin-antithrombin III complex, not a necessary cofactor for heparin&#39;s action.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasmin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Plasmin is involved in fibrinolysis (the breakdown of clots) and is not directly related to the anticoagulant action of heparin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombomodulin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Thrombomodulin is a receptor that binds thrombin and is involved in the activation of protein C, which has anticoagulant properties. However, it is not directly required for the action of heparin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The availability of antithrombin-III is mandatory for the anticoagulant action of heparin, as it forms a complex with heparin to inactivate key enzymes in the coagulation cascade.</span></span></span></p>",
    "correct_choice_id": 27982,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7004,
    "choices": [
      {
        "id": 27984,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">10%</span></span></span></p>"
      },
      {
        "id": 27985,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">100%</span></span></span></p>"
      },
      {
        "id": 27986,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">50%</span></span></span></p>"
      },
      {
        "id": 27987,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Variable</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the bioavailability of a drug administered intravenously?</span></span></p>",
    "unique_key": "Q6404018",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305630,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. 100%</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bioavailability of an administered drug is the fraction of that drug that reaches unchanged into systemic circulation. It depends upon 2 factors:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absorption of the drug from the site of application</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">First pass metabolism</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The bioavailability of a drug administered intravenously (I.V) is 100% because it is neither subjected to the first-pass metabolism as in oral route nor does it depend on local factors that affect absorption as in subcutaneous, intramuscular, or transdermal. In IV route, the drug is directly delivered to the systemic circulation and hence has the maximum availability for action at the intended site.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The bioavailability of a drug administered intravenously is 100% because the drug is directly delivered into the systemic circulation without any loss due to absorption barriers or first-pass metabolism.</span></span></span></p>",
    "correct_choice_id": 27985,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7005,
    "choices": [
      {
        "id": 27988,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1.8</span></span></span></p>"
      },
      {
        "id": 27989,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">10</span></span></span></p>"
      },
      {
        "id": 27990,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">14</span></span></span></p>"
      },
      {
        "id": 27991,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">18</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A drug solution containing 500 mg/5 ml of the drug is given to you. You are provided with a 2 ml syringe (having 10 divisions for each mI). How many divisions of the 2 m syringe need to be administered to deliver 180 mg of the drug to a patient? (</span></span></span>AIIMS May 2018)</p>",
    "unique_key": "Q9197548",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305631,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. 18</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">500 mg of the drug is present in 5ml of the solution.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, 180 mg will be present in (5/500) *180 = 1.8ml</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the syringe provided, 1ml = 10 divisions,</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore 1.8ml = 18 divisions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To deliver 180 mg of the drug using the provided 2 ml syringe with 10 divisions per ml, you need to fill the syringe to 18 divisions.</span></span></span></p>",
    "correct_choice_id": 27991,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6914,
    "choices": [
      {
        "id": 27624,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monitoring of lithium therapy</span></span></span></p>"
      },
      {
        "id": 27625,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monitoring of carbamazepine therapy</span></span></span></p>"
      },
      {
        "id": 27626,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Administration of long acting depot antipsychotics</span></span></span></p>"
      },
      {
        "id": 27627,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Administration of nicotine patches</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Z track technique is used for (</span></span></span>AIIMS Nov 2019)</p>",
    "unique_key": "Q8270281",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305632,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. C. Administration of long acting depot antipsychotics</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Z track technique is a technique used for intramuscular injection.</span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">During Z track technique, skin is stretched to one side before injecting the needle so that the point of injection and point of deposition of drug are not in straight line. This decreases the risk of efflux back of drug.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Advantages of Z track technique &ndash;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It will not cause any pigmentation</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Lithium and carbamazepine are oral drugs and monitoring is done by taking blood through intravenous route.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Long acting depot antipsychotics are given by intramuscular route via z-track technique.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Nicotine patches are applied on the skin.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Monitoring of lithium therapy:&nbsp;</span></strong></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium therapy is monitored through blood tests, not intramuscular injections. Blood samples are taken intravenously to measure lithium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Monitoring of carbamazepine therapy:&nbsp;</span></strong></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbamazepine therapy is also monitored through blood tests. Blood samples are taken intravenously to measure carbamazepine levels, and the medication is usually taken orally.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Administration of nicotine patches:&nbsp;</span></strong></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotine patches are applied transdermally to the skin. The Z track technique is not relevant for this method of administration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Z track technique is used for intramuscular injections, particularly for long-acting depot antipsychotics, to ensure proper deposition of the medication and prevent leakage back through the injection path.</span></span></span></p>",
    "correct_choice_id": 27626,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InstrumentsBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7012,
    "choices": [
      {
        "id": 28016,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endothelium independent coronary vasodilation</span></span></span></p>"
      },
      {
        "id": 28017,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduced cardiac contractility</span></span></span></p>"
      },
      {
        "id": 28018,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased left ventricular end diastolic volume</span></span></span></p>"
      },
      {
        "id": 28019,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased diastolic perfusion pressure</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with Prinzmetal angina is administered isosorbide mononitrate and is noticed to have symptomatic relief. What is the mechanism of action of nitrate in this case? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q3504325",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305633,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Endothelium independent coronary vasodilation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nitrates cause endothelium-independent coronary vasodilation when treating Prinzmetal angina.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Coronary artery vasospasm is the underlying cause of Prinzmetal angina. By relaxing the smooth muscles of the epicardial coronary arteries, nitrates treat coronary artery spasm.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The main mechanism of action of nitrates in the event of stable angina is preferred vein dilation (by increasing cGMP). Venous return to the heart is reduced as a result of venous dilatation (preload). Due to the reduction in ventricular end-diastolic volume, myocardial oxygen consumption also reduces.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced cardiac contractility</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is not the primary mechanism of action of nitrates in relieving Prinzmetal angina. Nitrates primarily work by vasodilation rather than affecting myocardial contractility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased left ventricular end diastolic volume</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nitrates generally reduce the preload (venous return) by dilating veins, which can lead to a decrease in left ventricular end-diastolic volume, not an increase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased diastolic perfusion pressure</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While nitrates can lower blood pressure, the primary therapeutic effect in Prinzmetal angina is not related to diastolic perfusion pressure but to the direct vasodilation of the coronary arteries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitrates provide symptomatic relief in Prinzmetal angina through endothelium-independent coronary vasodilation, which helps to alleviate coronary artery spasms and restore proper blood flow to the heart muscle.</span></span></p>",
    "correct_choice_id": 28016,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6885,
    "choices": [
      {
        "id": 27508,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vildagliptin</span></span></span></p>"
      },
      {
        "id": 27509,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Linagliptin</span></span></span></p>"
      },
      {
        "id": 27510,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Saxagliptin</span></span></span></p>"
      },
      {
        "id": 27511,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sitagliptin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a middle-aged diabetic patient with chronic kidney disease stage 5, which of the following drugs can be given safely without altering the dose? (</span></span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q3582394",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305634,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Linagliptin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The gliptins are DPP4 inhibitors used in the management of type 2 DM. They are eliminated through the kidneys and are therefore contraindicated in patients with CKD. Only Linagliptin can be safely administered in such cases, as it is eliminated through the hepatobiliary system.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Vildagliptin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Vildagliptin is excreted primarily through the kidneys. In patients with severe renal impairment (CKD stage 5), dose adjustments are necessary to avoid drug accumulation and toxicity.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Saxagliptin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Saxagliptin also undergoes significant renal excretion. Therefore, it requires dose adjustments in patients with severe renal impairment to ensure safe and effective use.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Sitagliptin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Similar to vildagliptin and saxagliptin, sitagliptin is primarily excreted by the kidneys. Dose adjustments are necessary in patients with advanced CKD to avoid the risk of adverse effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Linagliptin can be safely administered to patients with chronic kidney disease stage 5 without the need for dose adjustments due to its unique hepatobiliary excretion pathway, making it the preferred DPP-4 inhibitor in such cases.</span></span></span></p>",
    "correct_choice_id": 27509,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7013,
    "choices": [
      {
        "id": 28020,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adrenaline 0.5 mg 1/1000 IM</span></span></span></p>"
      },
      {
        "id": 28021,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adrenaline 1 mg 1/10000 IV</span></span></span></p>"
      },
      {
        "id": 28022,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine 3 mg</span></span></span></p>"
      },
      {
        "id": 28023,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenosine 6 mg followed by 12 mg IV</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The drug of choice in Anaphylactic Shock is? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q1332284",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305635,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Adrenaline 0.5 mg 1/1000 IM</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anaphylactic shock is a severe, life-threatening allergic reaction that requires immediate treatment. The first-line treatment for anaphylactic shock is the administration of adrenaline (epinephrine). Adrenaline works by counteracting the severe hypotension, bronchospasm, and edema that occur during anaphylactic reactions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Adrenaline 0.5 mg 1/1000 IM</span></strong><span style=\"font-size:12.0pt\"> is the recommended dose for the treatment of anaphylaxis. This intramuscular injection provides rapid absorption and action, which is critical in managing the symptoms of anaphylaxis effectively.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline 1 mg 1/10000 IV</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This dose and concentration of adrenaline are typically used in cardiac arrest scenarios, not for initial treatment of anaphylactic shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine 3 mg</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Atropine is used primarily to treat bradycardia (slow heart rate) and is not effective in managing anaphylactic shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosine 6 mg followed by 12 mg IV</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Adenosine is used to treat certain types of supraventricular tachycardia (SVT) and is not relevant for the treatment of anaphylactic shock.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-145658.jpg\" style=\"height:429px; width:1000px\" /></span></strong></span></span></p>",
    "correct_choice_id": 28020,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7014,
    "choices": [
      {
        "id": 28024,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No advice as most of drug are not present in breast milk</span></span></p>"
      },
      {
        "id": 28025,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Give longer half-life drugs</span></span></p>"
      },
      {
        "id": 28026,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tell the mother to feed when it is least efficacious</span></span></p>"
      },
      {
        "id": 28027,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To feed just before the next dose, when the plasma concentration of the drug would be the least</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What advice do you give to a mother who is using medications during lactation? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q6141993",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305636,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. To feed just before the next dose, when the plasma concentration of the drug would be the least</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">When administering medications to a lactating mother, the timing of breast feeding is very important. It is advised to feed the baby just before the intake of the drug, as at that time the plasma concentration of the drug would be least. Then after feeding the drug is taken.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. No advice as most of the drug are not present in breast milk</span></strong><span style=\"font-size:12.0pt\">: This is incorrect. Many drugs can pass into breast milk to varying degrees. Therefore, careful consideration and advice are needed to minimize infant exposure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Give longer half-life drugs</span></strong><span style=\"font-size:12.0pt\">: This is not a general recommendation. Drugs with longer half-lives stay in the body longer and can potentially accumulate in the breast milk, increasing exposure to the infant.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tell the mother to feed when it is least efficacious</span></strong><span style=\"font-size:12.0pt\">: This advice is not clear or practical. The key is to time breastfeeding relative to the dosing schedule to minimize drug transfer to the breast milk.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The best advice for a lactating mother using medications is to breastfeed just before taking her next dose of medication. This practice ensures that the drug&#39;s plasma concentration is at its lowest during breastfeeding, thereby reducing the amount of drug that passes into the breast milk and minimizing exposure to the infant.</span></span></p>",
    "correct_choice_id": 28027,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7015,
    "choices": [
      {
        "id": 28028,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids increase bronchial responsiveness to salbutamol</span></span></span></p>"
      },
      {
        "id": 28029,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids cause direct bronchodilatation when used with xanthine</span></span></span></p>"
      },
      {
        "id": 28030,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids indirectly increase the effect of xanthine on adenosine receptor</span></span></span></p>"
      },
      {
        "id": 28031,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids increase mucous secretion.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute exacerbation of asthma was comprehended, salbutamol was prescribed, however, no improvement was noticed. Intravenous corticosteroids and aminophylline were given and the condition improved. What is the probable mechanism by which the corticosteroids would have improved the condition? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q9016322",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305637,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Corticosteroids increase bronchial responsiveness to salbutamol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids are not bronchodilators by itself, but they are used in acute exacerbation of asthma because they decrease the secretion of mucous, decrease the inflammatory mediators and also increase the responsiveness of the &beta; receptors to the action of the &beta;2 agonists. Therefore, it can be said that Corticosteroids improved the condition by increasing the airway responsiveness to salbutamol.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corticosteroids cause direct bronchodilatation when used with xanthine</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect. Corticosteroids do not cause direct bronchodilation. Their primary role is to reduce inflammation and enhance the effects of bronchodilators.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corticosteroids indirectly increase the effect of xanthine on adenosine receptor</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect. Corticosteroids do not have a direct or indirect effect on the xanthine (aminophylline) action on adenosine receptors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corticosteroids increase mucous secretion</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect. Corticosteroids actually decrease mucus secretion, which helps to clear the airways and improve airflow during an asthma exacerbation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corticosteroids improve the condition of patients with acute asthma exacerbation by increasing the bronchial responsiveness to &beta;2 agonists like salbutamol, reducing inflammation, and decreasing mucus secretion.</span></span></p>",
    "correct_choice_id": 28028,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6889,
    "choices": [
      {
        "id": 27524,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Slowly taper the drug over next 6 months</span></span></span></p>"
      },
      {
        "id": 27525,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Continue levetiracetam since a 5-year seizure free interval is needed</span></span></span></p>"
      },
      {
        "id": 27526,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stop levetiracetam and start on a different anti-epileptic</span></span></span></p>"
      },
      {
        "id": 27527,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Discontinue the drug as he is seizure free</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An epileptic patient on levetiracetam has been seizure-free for 2 years. But he develops agitation and anger issues interfering with his day-to-day activities as a result of the drug intake. Which of the following measures is to be taken next? (</span></span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q6274359",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305638,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Slowly taper the drug over next 6 months</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Levetiracetam is an antiepileptic drug that binds to SV2A on the vesicles and modulates the release of Neurotransmitters. It can cause anger, agitation and mood disturbances as a side effect. In such cases, the drug should be gradually tapered over the next 6 months, but not abruptly stopped as that might lead to rebound seizures.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rationale for Tapering:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Side Effects:</span></strong><span style=\"font-size:12.0pt\"> The patient is experiencing significant side effects (agitation and anger) that are interfering with daily activities.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Seizure-Free Period:</span></strong><span style=\"font-size:12.0pt\"> While the patient has been seizure-free for 2 years, abruptly stopping the medication could lead to rebound seizures.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Gradual Tapering:</span></strong><span style=\"font-size:12.0pt\"> Tapering the medication slowly over the next 6 months is a safer approach. It allows the patient&#39;s body to adjust and reduces the risk of withdrawal seizures.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Continue levetiracetam since a 5-year seizure-free interval is needed:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While a longer seizure-free interval might be ideal, continuing the medication despite significant side effects is not practical. The patient&rsquo;s quality of life is important, and the side effects need to be addressed.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Stop levetiracetam and start on a different anti-epileptic:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Abruptly stopping levetiracetam is not recommended due to the risk of withdrawal seizures. Switching to a different antiepileptic drug (AED) should be done cautiously, and often a cross-tapering strategy is used.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Discontinue the drug as he is seizure-free:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Discontinuing the drug abruptly is not advisable, even if the patient has been seizure-free, because it could trigger rebound seizures. A gradual tapering is always preferred.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When a patient on levetiracetam experiences significant psychiatric side effects, the best approach is to slowly taper the medication over several months to prevent rebound seizures and address the side effects.</span></span></span></p>",
    "correct_choice_id": 27524,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6890,
    "choices": [
      {
        "id": 27528,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2.88mg/ml</span></span></span></p>"
      },
      {
        "id": 27529,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.004mg/ml</span></span></span></p>"
      },
      {
        "id": 27530,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3.55mg/ml</span></span></span></p>"
      },
      {
        "id": 27531,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.002mg/ml</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A drug was given IV at a rate of 1.6 mg/min. The clearance of the drug is 640 ml/min.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The half-life of the drug is 1.8 hour. Calculate the plasma concentration of the drug?(</span></span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q4126531",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305639,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. 0.002mg/ml</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Plasma conc of a drug (C) = Amount of drug being eliminated/Clearance</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">When the amount of drug administered equals the amount of drug eliminated from the body, steady-state plasma concentration is reached.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The amount of drug being administered = 1.6 mg/min</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clearance = 640ml/min</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore,</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Plasma concentration of the drug = 1.6 mg/min / 640 ml/min = 0.0025 mg/ml.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When given the rate of infusion and clearance, the steady-state plasma concentration of a drug can be calculated using the formula:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma&nbsp;concentration&nbsp;(C)=Rate&nbsp;of&nbsp;infusion&nbsp;(R)/ Clearance&nbsp;(Cl)</span></span></span></p>",
    "correct_choice_id": 27531,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7016,
    "choices": [
      {
        "id": 28032,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pentazocine</span></span></span></p>"
      },
      {
        "id": 28033,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Buprenorphine</span></span></span></p>"
      },
      {
        "id": 28034,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tramadol</span></span></span></p>"
      },
      {
        "id": 28035,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fentanyl</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following opioids is an antagonist at &lsquo;&micro;&rsquo; and a complete agonist at &lsquo;k&rsquo; receptors? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q4653389",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305640,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Pentazocine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pentazocine is an opioid agonist-antagonist agent, which acts as a full agonist at the Kappa receptors but as a partial agonist or antagonist at the mu receptors. It is used as an analgesic, but contraindicated in myocardial infarction due to its potential to increase heart rate and blood pressure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Buprenorphine</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Buprenorphine is a partial agonist at mu (&mu;) receptors and an antagonist at kappa (&kappa;) receptors. It is used for pain management and in the treatment of opioid dependence.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tramadol</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Tramadol is a weak agonist at mu (&mu;) receptors and also inhibits the reuptake of norepinephrine and serotonin. It does not have significant kappa (&kappa;) receptor activity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fentanyl</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fentanyl is a potent full agonist at mu (&mu;) receptors with no significant activity at kappa (&kappa;) receptors. It is used for severe pain management, particularly in surgical settings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pentazocine is an opioid that acts as an antagonist at mu (&mu;) receptors and a full agonist at kappa (&kappa;) receptors. This unique profile allows it to serve as an analgesic with a potentially lower risk of certain side effects, although it is contraindicated in myocardial infarction.</span></span></p>",
    "correct_choice_id": 28032,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6892,
    "choices": [
      {
        "id": 27536,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">70% amorphous 30% crystalline</span>&nbsp;</span></span></p>"
      },
      {
        "id": 27537,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">70% crystalline 30% amorphous</span></span></span></p>"
      },
      {
        "id": 27538,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Only 70% amorphous</span></span></span></p>"
      },
      {
        "id": 27539,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D Other name of NPH insulin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Composition of Lente insulin is? (</span></span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q8558183",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305641,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. 70% crystalline 30% amorphous</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lente insulin has two components in it:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ultralente insulin, which is water insoluble insulin zinc suspension with large crystalline particles (70%), it has a long half-life.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Semilente insulin, which is amorphous, has smaller particles and is short acting. (30%)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">These two components are mixed in this 7:3 ratio, making Lente insulin intermediate acting.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 70% amorphous 30% crystalline:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect as the amorphous part makes up only 30% of the composition in Lente insulin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Only 70% amorphous:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect because Lente insulin is a mixture of both crystalline and amorphous components, not just one type.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Other name of NPH insulin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Lente insulin and NPH (Neutral Protamine Hagedorn) insulin are different formulations. NPH insulin is an intermediate-acting insulin that is a suspension of insulin with protamine and zinc, which prolongs its action, but it is not referred to as Lente insulin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lente insulin is composed of 70% crystalline (long-acting) and 30% amorphous (short-acting) insulin, making it an intermediate-acting insulin formulation.</span></span></span></p>",
    "correct_choice_id": 27537,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6893,
    "choices": [
      {
        "id": 27540,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibition of M2 receptor</span></span></span></p>"
      },
      {
        "id": 27541,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Neuraminidase inhibition</span></span></span></p>"
      },
      {
        "id": 27542,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibition of RNA dependent DNA polymerase</span></span></span></p>"
      },
      {
        "id": 27543,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Apoptosis of infected cells</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of action of Oseltamivir as an antiviral agent is? (</span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q5169251",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305642,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Neuraminidase inhibition</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oseltamivir, commonly known by its brand name Tamiflu, is an antiviral medication primarily used to treat and prevent Influenza A and B. Its mechanism of action is as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neuraminidase inhibition</span></strong><span style=\"font-size:12.0pt\">: Oseltamivir works by inhibiting the viral enzyme neuraminidase. Neuraminidase is crucial for the viral life cycle because it cleaves sialic acid residues on the surface of host cells and on viral proteins, which facilitates the release of new viral particles from infected cells. By inhibiting neuraminidase, Oseltamivir prevents the release and spread of the virus, thus limiting the infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Inhibition of M2 receptor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. The M2 receptor is targeted by another antiviral drug, Amantadine, which is used against influenza A by inhibiting viral uncoating.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Inhibition of RNA dependent DNA polymerase:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Inhibition of RNA-dependent DNA polymerase is the mechanism of action for antiretroviral drugs like reverse transcriptase inhibitors used in HIV treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Apoptosis of infected cells:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Inducing apoptosis of infected cells is not the mechanism by which Oseltamivir works. It primarily prevents the release of new viral particles rather than directly inducing cell death.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oseltamivir is a neuraminidase inhibitor that is used to treat Influenza A and B. Inhibition of viral neuraminidase inhibits the release of viral progeny from the infected host cells.</span></span></span></p>",
    "correct_choice_id": 27541,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7017,
    "choices": [
      {
        "id": 28036,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprostene</span></span></p>"
      },
      {
        "id": 28037,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zerviate</span></span></p>"
      },
      {
        "id": 28038,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tasimelteon</span></span></p>"
      },
      {
        "id": 28039,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ramelteon</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The drug of choice for insomnia in blind people is? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q5966987",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305643,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Tasimelteon</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tasimelteon and Ramelteon are melatonin agonists. Tasimelteon is used for the treatment of insomnia in blind persons, whereas Ramelteon is used for the treatment of jet lag and also used for sleep induction.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprostene:</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is not relevant to the treatment of insomnia. It is a medication used to reduce intraocular pressure in patients with glaucoma or ocular hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zerviate: </span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Is an antihistamine eye drop used for the treatment of ocular itching associated with allergic conjunctivitis, not for insomnia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ramelteon:</span></strong> Is also a melatonin receptor agonist used for the treatment of insomnia, specifically for difficulties with sleep onset. It is not specifically indicated for Non-24-Hour Sleep-Wake Disorder in blind individuals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tasimelteon is the drug of choice for treating insomnia in blind individuals due to its effectiveness in regulating the sleep-wake cycle by acting as a melatonin receptor agonist, particularly in those with Non-24-Hour Sleep-Wake Disorder.</span></span></span></p>",
    "correct_choice_id": 28038,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6895,
    "choices": [
      {
        "id": 27548,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amitriptyline</span></span></span></p>"
      },
      {
        "id": 27549,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amlodipine</span></span></span></p>"
      },
      {
        "id": 27550,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chlorthalidone</span></span></span></p>"
      },
      {
        "id": 27551,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enalapril</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A male patient with a psychotic disorder is receiving antipsychotic, antidepressant, and antihypertensive medication. He developed tachycardia and chest tightness all of a sudden. He was diagnosed with metabolic acidosis. The ECG revealed a widened QRS complex and a prolonged QT interval. Which of the following drugs is the cause of this? (</span></span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q2067828",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305644,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Amitriptyline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amitriptyline is a tricyclic antidepressant (TCA). TCAs are known for their potential to cause significant cardiac toxicity, particularly in overdose situations. The mechanism includes:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cardiac Sodium Channel Blockade</span></strong><span style=\"font-size:12.0pt\">: This leads to a widened QRS complex on the ECG.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prolongation of QT Interval</span></strong><span style=\"font-size:12.0pt\">: TCAs can also block potassium channels, leading to a prolonged QT interval and potentially resulting in Torsades de pointes, a life-threatening arrhythmia.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Metabolic Acidosis</span></strong><span style=\"font-size:12.0pt\">: TCAs can cause metabolic acidosis due to their effects on the central nervous system and cardiovascular system, which can result in decreased perfusion and tissue hypoxia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Management</span></strong><span style=\"font-size:12.0pt\">: In cases of TCA overdose, the treatment of choice is intravenous sodium bicarbonate, which helps to narrow the QRS complex and stabilize the cardiac membrane.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Amlodipine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Amlodipine is a calcium channel blocker used for hypertension and angina. It does not typically cause a widened QRS complex or a prolonged QT interval and is not associated with metabolic acidosis in overdose situations.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chlorthalidone:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Chlorthalidone is a thiazide-like diuretic used for hypertension. It is not associated with the cardiac effects described (widened QRS, prolonged QT) or metabolic acidosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Enalapril:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used for hypertension and heart failure. It does not typically cause a widened QRS complex or prolonged QT interval and is not associated with metabolic acidosis in overdose situations.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amitriptyline is a TCA which can lead to widened QRS complex in the ECG along with prolonged QT interval-leading to Torsades de pointes. The antidote used in Amitriptyline toxicity is Sodium Bicarbonate.</span></span></span></p>",
    "correct_choice_id": 27548,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6896,
    "choices": [
      {
        "id": 27552,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ranitidine tablet before start of trip</span></span></span></p>"
      },
      {
        "id": 27553,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dimenhydrinate before start of trip</span></span></span></p>"
      },
      {
        "id": 27554,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scopolamine patch the night before trip</span></span></span></p>"
      },
      {
        "id": 27555,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Omeprazole the night before and before starts of trip</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">You and your friend plan for a mountain trip for the day after. What medication would you advise him to help with his motion sickness? (</span></span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q7030456",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305645,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Scopolamine patch the night before trip</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Scopolamine is an anticholinergic drug that is highly effective for the prevention and treatment of motion sickness. It works by blocking the muscarinic receptors in the central nervous system, which helps prevent the nausea and vomiting associated with motion sickness.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Transdermal Scopolamine Patch</span></strong><span style=\"font-size:12.0pt\">: The patch is typically applied behind the ear at least 4-5 hours before the trip and can provide continuous relief for up to 72 hours. This makes it highly convenient for trips that may last for several days</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ranitidine tablet before start of trip: </span></strong><span style=\"font-size:12.0pt\">Ranitidine is a histamine-2 receptor antagonist used to reduce stomach acid production. It is not effective for the prevention of motion sickness.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dimenhydrinate before start of trip: </span></strong><span style=\"font-size:12.0pt\">Dimenhydrinate (Dramamine) is an antihistamine that can be effective for treating motion sickness, but it requires more frequent dosing compared to the scopolamine patch. It is taken orally and must be dosed every 4-6 hours.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Omeprazole the night before and before start of trip: </span></strong><span style=\"font-size:12.0pt\">Omeprazole is a proton pump inhibitor used to reduce stomach acid production and treat gastroesophageal reflux disease (GERD). It is not effective for preventing motion sickness.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scopolamine, particularly in the form of a transdermal patch, is the drug of choice for the prevention of motion sickness. The patch should be applied the night before the trip to ensure it is effective in preventing the symptoms of motion sickness. Ranitidine and Omeprazole are not effective. Dimenhydrinate is an anti-histaminic drug which is not as effective as scopolamine.</span></span></span></p>",
    "correct_choice_id": 27554,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7018,
    "choices": [
      {
        "id": 28040,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class I</span></span></span></p>"
      },
      {
        "id": 28041,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class II</span></span></span></p>"
      },
      {
        "id": 28042,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>"
      },
      {
        "id": 28043,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class IV</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dofetilide belongs to which class of anti-arrhythmic drugs? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q7520380",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305646,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Class III</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dofetilide is a class III anti arrhythmic drug that works by blocking K+ channels. The other class III anti arrhythmic include Amiodarone, Ibutilide, Sotalol and bretylium.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The side effect is QT prolongation/Torsades de pointes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class I</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are sodium channel blockers. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class II</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are beta-blockers. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class IV</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are calcium channel blockers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III drugs include:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">B: Bretylium</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">I: Ibutilide</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">N</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">D: Dofetilide</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A: Amiodarone</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">S: Sotalol</span></span></span></p>",
    "correct_choice_id": 28042,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7019,
    "choices": [
      {
        "id": 28044,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cell wall synthesis inhibition</span></span></p>"
      },
      {
        "id": 28045,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cell membrane inhibition</span></span></p>"
      },
      {
        "id": 28046,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peptide synthesis inhibition</span></span></p>"
      },
      {
        "id": 28047,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">50S ribosome inhibition</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the mechanism of action of vancomycin? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q6639734",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305647,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Cell wall synthesis inhibition</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin binds to the D-Ala-D-Ala terminus of the newly formed peptidoglycan pentapeptide. This prevents further elongation of the peptidoglycan and its cross-linking by inhibiting transglycolase. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin is a bactericidal agent used against gram positive agent like MRSA.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cell membrane inhibition</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is not the mechanism of action of vancomycin. Drugs like polymyxins target the cell membrane.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peptide synthesis inhibition</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option is incorrect. Peptide synthesis inhibition is typically the mechanism of action for drugs like tetracyclines and macrolides that interfere with ribosomal function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">50S ribosome inhibition</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is not the mechanism of action of vancomycin. Drugs like macrolides (e.g., erythromycin), chloramphenicol, and clindamycin inhibit the 50S ribosomal subunit.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin inhibits bacterial cell wall synthesis by binding to the D-Ala-D-Ala terminus of peptidoglycan precursors, preventing peptidoglycan elongation and cross-linking, leading to cell lysis and death. It is especially effective against gram-positive bacteria like MRSA.</span></span></p>",
    "correct_choice_id": 28044,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6899,
    "choices": [
      {
        "id": 27564,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Excretion in saliva </span></span></span></p>"
      },
      {
        "id": 27565,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Excretion in urine </span></span></span></p>"
      },
      {
        "id": 27566,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Large volume of distribution </span></span></span></p>"
      },
      {
        "id": 27567,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small volume of distribution </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following suggests storage of drugs in tissue (</span></span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q3494864",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305648,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Large volume of distribution </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Large volume of distribution suggests storage of drugs in tissue. The volume of distribution (Vd) is a pharmacokinetic parameter that reflects the extent of drug distribution throughout the body. A large Vd indicates that a drug is extensively distributed throughout the tissues, including organs and fluids. This suggests that the drug is likely to be stored in the tissues and may have a long half-life. In contrast, a small Vd indicates that the drug is primarily confined to the bloodstream and has limited distribution to the tissues. Excretion in saliva or urine does not necessarily suggest storage of drugs in tissues, and the volume of distribution is not directly related to excretion.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Excretion in saliva:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Excretion in saliva does not provide direct information about the extent of drug distribution or storage in tissues. It is more related to the route of elimination.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Excretion in urine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Excretion in urine indicates renal elimination of the drug or its metabolites. It provides information about the drug&#39;s elimination route but not about its distribution or storage in tissues.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Small volume of distribution:&nbsp;</span></strong><span style=\"font-size:12.0pt\">A small Vd indicates that the drug is largely confined to the bloodstream and has limited distribution to the tissues. This means the drug is not significantly stored in the tissues and is more likely to be readily available in the blood for excretion.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A large volume of distribution (Vd) suggests that a drug is extensively distributed and stored in the body&#39;s tissues, which can result in a prolonged half-life and slower elimination from the body.</span></span></span></p>",
    "correct_choice_id": 27566,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7020,
    "choices": [
      {
        "id": 28048,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;1 agonist and &beta;1 agonist</span></span></span></span></span></p>"
      },
      {
        "id": 28049,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffM2 agonist and M3 agonist</span></span></span></span></span></p>"
      },
      {
        "id": 28050,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeff&alpha; 1 antagonist and &beta;2 agonist</span></span></span></span></span></p>"
      },
      {
        "id": 28051,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">\ufeff\ufeff\ufeff<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;1 agonist and &beta;2 agonist</span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following table gives BP values before and after administration of drug &#39;X&#39;. What would be the probable mechanism of action of drug &#39;X&#39;?</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (AIIMS MAY 2017)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-150657.jpg\" style=\"height:296px; width:687px\" /></span></span></p>",
    "unique_key": "Q8253266",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305649,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;1 agonist and &beta;2 agonist</span></strong></span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The drug&#39;s likely mechanism of action is &beta;1 and &beta;2 agonism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Due to its action on &beta;1 receptors, there is an increase in the HR of the patient and also of the SBP (Increase in HR leads to an increase in the CO upto a certain extent). The agonistic action on the &beta;2 receptors causes vasodilation and leads to a fall in the DBP.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;1 agonist and &beta;1 agonist</span></strong>: &alpha;1 agonists typically cause vasoconstriction, which would increase both SBP and DBP. This does not align with the observed decrease in DBP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M2 agonist and M3 agonist</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: M2 and M3 receptor agonism would likely lead to bradycardia and increased gastrointestinal motility, respectively. They do not explain the observed increase in HR and SBP, nor the decrease in DBP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;1 antagonist and &beta;2 agonist</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While &alpha;1 antagonism could contribute to a decrease in DBP through vasodilation, it would not typically cause an increase in SBP and HR, which are more specifically associated with &beta;1 agonism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The combination of increased systolic blood pressure, decreased diastolic blood pressure, and increased heart rate suggests that drug &#39;X&#39; acts as a &beta;1 and &beta;2 agonist, leading to increased cardiac output and vasodilation.</span></span></p>",
    "correct_choice_id": 28051,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7029,
    "choices": [
      {
        "id": 28084,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Hydrocortisone</span></p>"
      },
      {
        "id": 28085,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Potassium binding resin</span></p>"
      },
      {
        "id": 28086,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Digoxin</span></p>"
      },
      {
        "id": 28087,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Calcium gluconate</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">An 18-month-old child with ambiguous genitalia presented to the hospital, his </span><span style=\"font-size:12.0pt;\">BP is 88/68 mm Hg</span><span style=\"font-size:12pt;\">, Serum K<sup>+</sup> is 6 mEq/L, serum sodium is 120 mEq/L. Patient was started on intravenous fluids. What additional specific therapy will you add?</span></p>",
    "unique_key": "Q9436180",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305650,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Hydrocortisone</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The presentation of an 18-month-old child with ambiguous genitalia, hypertension (BP is 88/68 mm Hg, which is low for this age), hyperkalemia (serum K of 6 mEq/L), and hyponatremia (serum sodium of 120 mEq/L) is suggestive of congenital adrenal hyperplasia (CAH), most likely due to 21-hydroxylase deficiency. This is a common form of CAH and can lead to a decrease in cortisol and aldosterone production, with an accompanying increase in adrenal androgens.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Given this clinical picture, the specific therapy to be added would include:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Glucocorticoid Replacement:</strong> This is critical to suppress the overproduction of adrenal androgens. Hydrocortisone is commonly used, especially in pediatric patients, due to its short duration of action and lower impact on growth.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mineralocorticoid Replacement:</strong> Fludrocortisone is usually added to manage the aldosterone deficiency, which is contributing to the hyperkalemia and hyponatremia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Sodium Chloride Supplements:</strong> In some cases, especially in infants and young children, additional sodium chloride supplements may be necessary to manage hyponatremia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Monitoring and Adjustment:</strong> Regular monitoring of electrolytes, blood pressure, and growth is necessary to adjust therapy accordingly.</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B</strong>. <strong>Potassium Binding Resins:</strong> While these can be used to treat hyperkalemia, they do not address the underlying cause of the electrolyte imbalance in this scenario, which is likely due to aldosterone deficiency. Therefore, it would not be the first choice.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C</strong>. <strong>Digoxin:</strong> This is used primarily for heart failure and certain arrhythmias, not for the conditions described in this scenario.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D</strong>. <strong>Calcium Gluconate:</strong> This is used in the acute management of severe hyperkalemia to stabilize cardiac membranes. While it might be used in an emergency setting for life-threatening hyperkalemia, it does not address the underlying cause in this case and is not a long-term management strategy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Therefore, the most appropriate addition to this patient's treatment regimen would be <strong>Hydrocortisone</strong> (option a), as it addresses the underlying cause of the symptoms in CAH. Additionally, monitoring and adjusting mineralocorticoid therapy (like fludrocortisone) would be important in the long-term management, especially given the electrolyte imbalances.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most appropriate addition to this patient's treatment regimen would be Hydrocortisone, as it addresses the underlying cause of the symptoms in CAH. Additionally, monitoring and adjusting mineralocorticoid therapy (like fludrocortisone) would be important in the long-term management, especially given the electrolyte imbalances.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/314</strong></span></p>",
    "correct_choice_id": 28084,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7030,
    "choices": [
      {
        "id": 28088,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">1, 3 and 4 are correct</span></p>"
      },
      {
        "id": 28089,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Only 2 is correct</span></p>"
      },
      {
        "id": 28090,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">1 and 2 are correct</span></p>"
      },
      {
        "id": 28091,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">All are correct</span></p>"
      }
    ],
    "text": "<p><span style=\"color:#333333;font-size:12pt;\">Chlorpromazine is an antipsychotic drug. It also produces sedation and adverse effects like dry mouth and hypotension. All these actions result due to action on which of the following receptors?(INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">1. D2 and 5HT2 receptors</span></p><p><span style=\"color:#333333;font-size:12pt;\">2. GABA and Beta-adrenergic receptors</span></p><p><span style=\"color:#333333;font-size:12pt;\">3. Muscarinic and alpha-adrenergic receptors</span></p><p><span style=\"color:#333333;font-size:12pt;\">4. H1 receptors</span></p>",
    "unique_key": "Q9412442",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305651,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. 1, 3 and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Chlorpromazine&nbsp;</strong>is a typical anti-psychotic drug having main mechanism of antipsychotic action as D2 blockade and minor as 5 HT2 blockade. However, it also blocks many other receptors that can result in adverse effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While chlorpromazine does block H1 receptors causing sedation, it is not the sole receptor responsible for its adverse effects. It must be considered in conjunction with D2, 5HT2, muscarinic, and alpha-adrenergic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. GABA and Beta-adrenergic Receptors:&nbsp;</strong>Chlorpromazine does not primarily act on GABA or beta-adrenergic receptors, hence this option is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Actions of anti-psychotic drugs</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-154713.png\" alt=\"\" width=\"1000\" height=\"352\"></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/470-471</strong></span></p>",
    "correct_choice_id": 28088,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7031,
    "choices": [
      {
        "id": 28092,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Sialorrhea</span></p>"
      },
      {
        "id": 28093,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Anorgasmia</span></p>"
      },
      {
        "id": 28094,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Nausea</span></p>"
      },
      {
        "id": 28095,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Vivid dreams</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">A bank employee, felt depressed with no interest in activities, came to AIIMS OPD. He was started on escitalopram. Which of these adverse effects cannot be explained with escitalopram? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q1752586",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305652,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. Sialorrhea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sialorrhea, or excessive saliva production, is not a common side effect of SSRIs like escitalopram. It is more commonly associated with the atypical antipsychotic drug clozapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anorgasmia:&nbsp;</strong>Anorgasmia, or difficulty achieving orgasm, is a well-known side effect of SSRIs due to their impact on serotonin levels, which can interfere with sexual function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nausea:&nbsp;</strong>Nausea is one of the most common side effects of SSRIs. It typically occurs at the beginning of treatment and may subside with continued use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vivid dreams:&nbsp;</strong>Vivid dreams are another common side effect of SSRIs. They occur due to the influence of increased serotonin levels on sleep patterns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">Escitalopram is a Selective Serotonin Reuptake Inhibitor (SSRI).</span></li><li><span style=\"color:#333333;font-size:12pt;\">Other SSRIs include Fluoxetine, Paroxetine, Fluvoxamine etc.</span></li><li><span style=\"color:#333333;font-size:12pt;\">Side-effects of SSRI include:</span></li><li><span style=\"color:#333333;font-size:12pt;\">Most common: Nausea, Vomiting</span></li><li><span style=\"color:#333333;font-size:12pt;\">Next most common: Anxiety etc.</span></li><li><span style=\"color:#333333;font-size:12pt;\">Other side effects- Delayed ejaculation, anorgasmia, diarrhea, vivid dreams etc.</span></li><li><span style=\"color:#333333;font-size:12pt;\">Main drug which causes sialorrhea is CLOZAPINE (an atypical anti-psychotic drug)</span></li></ul><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/488</strong></span></p>",
    "correct_choice_id": 28092,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7032,
    "choices": [
      {
        "id": 28096,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Topical mupirocin</span></p>"
      },
      {
        "id": 28097,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Oral Vancomycin</span></p>"
      },
      {
        "id": 28098,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Inhaled colistin</span></p>"
      },
      {
        "id": 28099,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">IV cefazolin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">There was outbreak of MRSA in the hospital, and it was found that a nurse of NICU had MRSA colonization of anterior nares. What is the best treatment?(INICET MAY 2024)</span><br>&nbsp;</p>",
    "unique_key": "Q2397479",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305653,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. Topical mupirocin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">Anterior nares are the most common site of colonization in carrier state of MRSA.</span></li><li><span style=\"color:#333333;font-size:12pt;\"><strong>Mupirocin (</strong>2% topical cream<strong>)&nbsp;</strong>is DOC for MRSA carriers. Other drug that can be used is topical Bacitracin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Oral Vancomycin:&nbsp;</strong>Vancomycin is typically used for systemic MRSA infections and is administered intravenously due to poor oral absorption. It is not appropriate for eradicating nasal colonization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Inhaled colistin:&nbsp;</strong>Colistin is used for multi-drug-resistant gram-negative infections and is not indicated for MRSA, especially not for nasal colonization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. IV cefazolin:&nbsp;</strong>Cefazolin is a first-generation cephalosporin effective against methicillin-sensitive Staphylococcus aureus (MSSA) but not MRSA. It is also not suitable for treating nasal colonization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For MRSA colonization in the anterior nares, topical mupirocin is the best treatment due to its targeted action, efficacy, and minimal systemic side effects.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/809</strong></span></p>",
    "correct_choice_id": 28096,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7033,
    "choices": [
      {
        "id": 28100,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">b, d and e only</span></span></span></p>"
      },
      {
        "id": 28101,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">c and e only</span></span></span></p>"
      },
      {
        "id": 28102,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">a and c only</span></span></span></p>"
      },
      {
        "id": 28103,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only e is correct</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Mention&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">the true statement/s about drug resistant malaria: (</span></span></span></span>AIIMS May 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It is not present in India.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Quinine with clindamycin or doxycycline is still effective treatment.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Chloroquine with sulfadoxine-pyrimethamine is effective.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Artemether with lumefantrine is useful.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Monotherapy with artemisinin derivatives is not useful due to high risk of recrudescence.</span></span></span></span></li>\r\n</ol>",
    "unique_key": "Q7965419",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305654,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A. b, d and e only</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Plasmodium falciparum is now the most common cause of malaria as well as most common cause of drug resistant malaria in India (Option a is false)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">DOC for multiple drug resistant P falciparum is artemisinin compounds, but they are short acting. The short action is responsible for recrudescence when used as monotherapy in malaria. So they are combined with long acting drugs (known as ACT; Artemisinin based Combination Therapy) like&nbsp;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Artemether + Lumefantrine: DOC in North-Eastern states.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Artesunate + Sulfadoxine/Pyrimethamine: DOC all over India except NE states.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Artemisinin&rsquo;s are contraindicated in first trimester of pregnancy; but can be given in second and third trimester.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">So, if drug resistant malaria occurs in 1st trimester of pregnancy, DOC is Quinine. To reduce its toxicity, we commonly add clindamycin (in pregnancy and children) or doxycycline (in other patients).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Chloroquine is not effective in drug resistant malaria. So artesunate (not Chloroquine) is combined with sulfadoxine-pyrimethamine (Option c) &nbsp;</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Other Options:</span></span></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It is not present in India.&nbsp;</span></strong><span style=\"font-size:12.0pt\">False. Drug-resistant malaria is present in India. Plasmodium falciparum, known for drug resistance, is a common cause of malaria in India.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chloroquine with sulfadoxine-pyrimethamine is effective.&nbsp;</span></strong><span style=\"font-size:12.0pt\">False. Chloroquine is not effective in drug-resistant malaria. Artemisinin-based combination therapies (ACTs) are preferred.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drug-resistant malaria in India is effectively treated with ACTs like Artemether with lumefantrine. Monotherapy with artemisinin derivatives is avoided due to the risk of recrudescence.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/876-877</span></span></strong></span></span></p>",
    "correct_choice_id": 28100,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6898,
    "choices": [
      {
        "id": 27560,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bradycardia</span></span></span></p>"
      },
      {
        "id": 27561,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tachycardia</span></span></span></p>"
      },
      {
        "id": 27562,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases urine output</span></span></span></p>"
      },
      {
        "id": 27563,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases mean arterial blood pressure</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient of septicemia was treated with norepinephrine infusion. Which of the following best parameter is used to monitor the effect of therapy? (</span></span>AIIMS Nov 2017)</p>",
    "unique_key": "Q1092998",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305655,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Increases mean arterial blood pressure</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Norepinephrine/ Noradrenaline, is a vasopressor commonly used in the management of septic shock. It works primarily by stimulating &alpha;1 and &alpha;2 adrenergic receptors, leading to vasoconstriction and an increase in systemic vascular resistance. It also stimulates &beta;1 receptors, which increases cardiac output.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Increase in Mean Arterial Blood Pressure (MAP)</span></strong><span style=\"font-size:12.0pt\">: The primary goal of using norepinephrine in septic shock is to improve perfusion by increasing MAP. Monitoring MAP is essential because it provides a direct measure of the pressure needed to ensure adequate blood flow to organs. An increase in MAP indicates improved perfusion and is a key indicator of the efficacy of norepinephrine therapy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bradycardia:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Bradycardia can occur as a reflex response to the increase in blood pressure caused by norepinephrine. However, it is not a primary parameter for monitoring the therapeutic effect of norepinephrine in septic shock.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tachycardia:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Tachycardia is not typically expected with norepinephrine therapy and can be a sign of other issues or a compensatory response. It is not a direct indicator of norepinephrine efficacy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Increases urine output:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While increased urine output is a good sign of improved renal perfusion and overall hemodynamic status, it is a secondary measure. The primary aim is to stabilize the patient&#39;s blood pressure, making MAP the more direct parameter to monitor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Noradrenaline acts on the &alpha;1, &alpha;2 and &beta;1 receptors. It leads to an increase in the SBP, a rise in DBP and therefore a rise in MAP. This helps in improving the perfusion in patients suffering from septic shock. The rise in mean arterial pressure also causes reflex bradycardia but it is not a major contributor to the treatment of septic shock</span></span></span></p>",
    "correct_choice_id": 27563,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7021,
    "choices": [
      {
        "id": 28052,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">18</span></span></span></p>"
      },
      {
        "id": 28053,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1.8</span></span></span></p>"
      },
      {
        "id": 28054,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">20</span></span></span></p>"
      },
      {
        "id": 28055,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftriaxone 180 mg is required for a patient. You&#39;re using a 2 mL syringe with 10 divisions per ml. Ceftriaxone 500 mg/5ml is contained in the vial. How many divisions will you fill in the 2 mL syringe to give 180 mg ceftriaxone? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q7918327",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305656,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. 18</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a vial of Ceftriaxone, it is given than 500mg is there in 5ml.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore 180 mg will be present in 1.8 ml.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the 2ml syringe there are 10 divisions per ml.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thus, to take 1.8ml, we need to fill 10*1.8 = 18 divisions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To administer 180 mg of ceftriaxone using a 2 mL syringe with 10 divisions per ml, you need to fill the syringe to 18 divisions.</span></span></p>",
    "correct_choice_id": 28052,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7039,
    "choices": [
      {
        "id": 28124,
        "text": "<p><span style=\"font-size:12pt;\">Proguanil</span></p>"
      },
      {
        "id": 28125,
        "text": "<p><span style=\"font-size:12pt;\">Sulindac</span></p>"
      },
      {
        "id": 28126,
        "text": "<p><span style=\"font-size:12pt;\">Primidone</span></p>"
      },
      {
        "id": 28127,
        "text": "<p><span style=\"font-size:12pt;\">5-Fluorouracil</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not a prodrug? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q9157458",
    "question_audio": null,
    "question_video": null,
    "map_id": 33305657,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Primidone</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Prodrugs are drugs that are present in their inactive form and are converted to the active form in the body after undergoing metabolism.</span></li><li><span style=\"font-size:12pt;\">Among the given options primidone is not a prodrug. Although it produces active metabolites like phenobarbitone and phenylethylmalonamide (PEMA) but it cannot be considered as a prodrug because primidone itself is also active.</span></li></ul><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>A.</strong> <strong>Proguanil:</strong> Proguanil is a prodrug and its active metabolite is cycloguanil. It is used in the treatment and prevention of malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>C.</strong> <strong>Sulindac</strong>: Sulindac is a sulfoxide prodrug used in inflammatory diseases including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>D. Flurouracil:</strong> Flurouracil&nbsp; is a prodrug having the active metabolite as fluorouridine monophosphate. It is an anticancer chemotherapeutic agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Primidone is not a prodrug because it is pharmacologically active in its original form, although it also produces active metabolites. Prodrugs like Proguanil, Sulindac, and 5-Fluorouracil require metabolic activation to exert their therapeutic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Mnemonic</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-101615.png\" alt=\"\" width=\"1000\" height=\"418\"></p>",
    "correct_choice_id": 28126,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq (Inicet, Pharmacology-2)';
        const quizFilename = 'late-night-pyq-inicet-pharmacology-2-82cb2ec5.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>